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IN VITRO AND IN VIVO ANALYSIS OF THE ASSEMBLY OF THE NON-
COLLAGENOUS TECTORIAL MEMBRANE MATRIX 
SUMMARY 
Alpha- and beta-tectorin (Tecta and Tectb) are major non-collagenous components of 
the tectorial membrane (TM). The presence of a zona pellucida (ZP) domain in both 
tectorins suggests that Tecta and Tectb can form hetero- or homopolymers. It is unclear, 
however, how these proteins assemble to form the TM matrix. The mechanisms of 
apical targeting, secretion and processing of the tectorins are also unexplored. I used 
fluorescently-tagged tectorin constructs for stable transfection into polarised epithelial 
MDCK cells or transient expression in mouse cochlear cultures to develop an in vitro 
model of TM matrix assembly. Significant amounts of matrix were not observed with 
stable tectorin expression in monolayer cultures of MDCK cells. In contrast, I observed 
substantial amounts of dense extracellular matrix on the apical surfaces of outgrowth 
zone cells when cochlear cultures were transiently transfected with either Tecta or 
Tectb. When ectopically expressed in hair cells, Tecta and Tectb locate to the distal tips 
of the hair bundle.  
To study the role of the inner-ear protein Ceacam16 in hearing, we generated a 
Ceacam16 functional null mouse model. The Ceacam16 gene was inactivated by 
targeted replacement of exons 2-5 with the bacterial lacZ gene. β-gal staining I 
performed reveals that Ceacam16 is expressed in the epithelial cells of the spiral limbus 
and inner sulcus, and in both the pillar cells and Deiter’s cells. I first detected the 
  
presence of Ceacam16 in the TM at P12, four days before the defined striated-sheet 
matrix is observed. Transmission electron microscopy reveals a complete loss of 
striated-sheet matrix in Ceacam16 null mice in comparison to the wild-type.  
The results of this thesis suggest neonatal mouse cochlear cultures as a model for 
studying tectorin-based extracellular matrix production and also reveal that Ceacam16 is 
required for normal formation and/or maintenance of striated-sheet matrix. 
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CHAPTER 1 
General Introduction 
1.1. Anatomy and physiology of the mammalian auditory periphery  
The mammalian ear comprises three parts, each of which plays a particular role in the 
perception of sound; these are the outer, middle and inner ears (Fig.1.1). The outer ear is 
composed of an external cartilaginous section referred to as the pinna or the auricle. The 
pinna, in turn, consists of the concha, which forms a reverberating hollow space 
connected by the ear canal (external auditory meatus) to the eardrum or tympanic 
membrane (Fig.1.1) (Geisler, 1998). The outer ear collects sound waves, transmitting 
them to the more interior portions. It selectively strengthens and weakens sound stimuli 
of particular frequencies and directions (Rosowski, 1996). The eardrum is an elastic, 
fine membrane that separates the outer and middle ears.  
The middle ear transmits sound from the ear canal to the inner ear. Its primary function 
is to compensate for the impedance mismatch between the two different media of the 
ear: the air-filled outer ear and the liquid-filled inner ear (Pickles, 1988). The ossicles 
(Fig.1.1), a chain of minute bones named the malleus (hammer), the incus (anvil) and 
the stapes (stirrup), render sound transmission through the mammalian middle ear 
(Pickles, 1988; Geisler, 1998). The malleus is most lateral and adjoins the medial aspect 
of the eardrum. The footplate of the stapes is affixed to the oval window in the bony 
wall of the inner ear (Pickles, 1988). 
13 
 
The inner ear includes the vestibular system (the organ of balance), and the cochlea (the 
organ of hearing) (Klinke, 1986). The cochlea translates sound waves into action 
potentials encoding auditory information for processing in the central nervous system. 
 
Figure1.1. The outer, middle and inner ears in man. The size of the inner and middle ear structures 
has been magnified (from Geisler, 1998). 
1.2. General structure of the cochlea 
The cochlea (“snail” in Latin) is a small, coiled, bony structure split into three ducts 
filled with liquid: scala vestibuli, scala media and scala tympani (Fig.1.2) (Geisler, 
1998). Scala vestibuli and scala tympani are filled with perilymph, which is akin to 
extracellular fluid (Pickles, 1988) and scala media is filled with endolymph, resembling 
intracellular fluid (Bosher and Warren, 1978). Scala vestibuli begins at the oval window, 
a membrane between the middle ear and the inner ear which is in direct contact with 
stapes (Fig.1.1). Scala tympani terminates at the round window, another membrane 
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within the osseous wall of the cochlea, which is situated below the oval window 
(Fig.1.1) and allows the pressure caused by the quivering of the stapes to be released 
back in the middle ear.  A small hole, the helicotrema, provides a connection between 
scala vestibuli and scala tympani at the cochlear apex. 
Scala media is enclosed between scala vestibuli and scala tympani (Fig.1.2) and its 
boundaries are formed by two elastic membranes. Reissner’s membrane separates scala 
media from scala vestibuli and is insensitive to sound waves (von Bekesy, 1960). The 
basilar membrane (BM) forms the boundary between scala media and scala tympani and 
is sensitive to sound waves. The BM consists of collagen fibres embedded in an 
amorphous matrix. It stretches radially from the osseous spiral lamina to the spiral 
ligament, located at the outer wall of the cochlea (Geisler, 1998; von Bekesy, 1948). 
The fluid content of scala media is referred to as the endolymph.  
 
Figure 1.2. A cross-section through the cochlea displaying the scalae and related structures of the 
mammalian cochlea (from Geisler, 1998). 
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The cochlea acts as a frequency analyser (von Bekesy, 1960). It separates a complex 
sound wave into its component frequencies and maps them along the BM (Dallas, 1992; 
von Bekesy, 1960). The motion of the BM occurs in a form of a travelling wave which 
starts at the base of the cochlea and terminates at the apex (von Bekesy, 1960). The 
place where the BM displacement reaches its maximum depends on the frequency of the 
stimulus, and is the characteristic frequency (CF) of this point along the BM. High 
frequencies cause maximum vibrations at the base of the cochlea, and low frequencies 
peak at the apex (von Bekesy, 1960). This is reflected in the shape and physical 
properties of the BM which is thick, narrow and stiff in the basal turn of the cochlea, but 
is broad, thin and floppy at cochlear apex (von Bekesy, 1960).  
1.3. The structure of the organ of Corti 
On upper surface of the BM sits the complex, cellular structure referred as the organ of 
Corti. The organ of Corti is comprised of the hair cells, which are the receptor cells that 
transform sound oscillations into neural activity, and the supporting cells that provide 
structural support and play the diverse roles in the development and maturation of the 
sensory epithelia.  
Two distinct types of hair cells are distinguished in the organ of Corti: the inner hair 
cells (IHCs) and outer hair cells (OHCs). The IHCs are arranged linearly along the 
modiolar face of the tunnel of Corti and their lateral boundaries are defined by the inner 
pillar cells (Fig.1.3). The OHCs are arranged into three rows on the other side of the 
tunnel of Corti. Both types of hair cells are crowned at their apical surfaces with a stiff 
cuticular plate comprised of actin and other cytoskeletal proteins, from which the hair 
bundles protrude (Fettiplace and Hackney, 2006). Supporting cells surround the hair 
cells and prevent them from directly contacting each other. The apical extremities of 
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supporting and hair cells are joined together by tight junctions, adherens junctions and 
desmosomes to produce the reticular lamina (Raphael and Altschuler, 2003). Deiters’ 
cells support the OHCs at their base and apex (Geisler, 1998) and form protrusions 
which extend to the reticular lamina and fill spaces between OHCs (Raphael and 
Altschuler, 2003). An inner phalangeal cell and a border cell support and isolate an IHC. 
The pillar cells form the tunnel of Corti and provide mechanical coupling between the 
BM and the reticular lamina (Tolomeo and Holley, 1997). Tall columnar Hensen’s cells 
adjacent to the third row of Deiter’s cells (Fig.1.3) might regulate the ion balance of the 
endolymph (Lagostena et al., 2001; Sugasawa et al., 2013). The organ of Corti is 
covered by the tectorial membrane (TM), an acellular structure which is attached to the 
spiral limbus and extends parallel to the BM (Fig.1.3). Transverse oscillations of the 
BM in response to sound stimulation induce a radial shearing movement of the hair 
cells against the TM, deflecting their hair bundles thus causing their depolarisation and 
transmitter release (Geisler, 1998). 
The IHCs have dense afferent innervation and are thought to be the main sensory cells 
of the cochlea. Their hair bundles are free-standing and are stimulated by the fluid 
motion in the subtectorial space. The OHC hair bundles are imbedded in the TM 
(Kimura, 1966). Efferent fibres synapse directly on the OHCs and on the afferent 
dendrites under IHCs (Spoendlin, 1985). The OHCs are able to change their length and 
shape in response to electrical stimulation (Brownell et al., 1985). This property known 
as somatic electromotility serves to amplify the vibrations of the BM at low sound 
pressure levels and compress the BM response at high sound pressure levels (Robles 
and Ruggero, 2001). 
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Figure 1.3. Cross-section through the organ of Corti (modified from Fettiplace and Hackney, 2006). 
1.4. The tectorial membrane 
1.4.1. The structure of the tectorial membrane 
The tectorial membrane (TM) comprises three distinct zones (Fig.1.4): the marginal 
zone consisting of the marginal band; the middle zone which forms the main body of 
the TM; and the limbal zone where the TM attaches to osseous spiral limbus. 
The main body of the TM is packed with striated-sheet matrix and bundles of collagen 
fibres (Fig.1.4). Its upper surface is covered by the covernet, which merges into the 
marginal band. Hensen’s stripe and Kimura’s membrane are situated on the lower 
surface of the TM (Fig.1.4). The tallest row of stereocilia on each OHC is imbedded 
into Kimura’s membrane, which lies over all three rows of OHCs and continues into the 
marginal band (Kimura, 1966; Lim, 1980). The position of Hensen’s stripe corresponds 
to the row of IHCs (Lim, 1980; Rueda et al., 1996).  
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The TM contains three types of collagen, types II, IX and XI, and the non-collagenous 
glycoproteins: alpha-tectorin (Tecta) and beta-tectorin (Tectb) (Legan et al., 1997; 
Richardson et al., 1987), otogelin (Cohen-Salmon et al., 1997), and the recently 
described protein Ceacam16 (Zheng et al., 2011). Recent studies suggest that otogelin-
like (OTOGL) (Yariz et al., 2012) and otolin (Deans et al., 2010) are non-collagenous 
glycoproteins that contribute to the TM. 
Collagen bundles are interwoven with the striated-sheet matrix. The Tectb
-/- 
mice 
(Russell et al., 2007) and mice with a functional null mutation in Tecta (Tecta
ΔENT/ΔENT
) 
(Legan et al., 2000) lack a striated-sheet matrix suggesting that it is formed of Tecta and 
Tectb proteins. Another possible component involved in striated-sheet matrix formation 
is Ceacam16 protein which was shown to interact with Tecta (Zheng et al., 2011). 
Although Kammerer et al., 2012, generated a Ceacam16
-/-
 mouse model they did not 
performed full ultrastructural analysis. However, it was shown that Ceacam16 protein 
appears in the TM from a postnatal day 12 (P12), coincidentally with the onset of 
hearing in mice (Kammerer et al., 2012). The data of Simmler et al., 2000, indicate that 
otogelin is involved in the TM fibrillar network and might be associated with collagen 
fibrils. In the otogelin null mice, large areas of the TM have a disrupted fibrillar 
organization with collagen bundles forming either scattered, wavy strands or dense, rod-
like fibrils (Simmler et al., 2000). The striated-sheet matrix in the otogelin null mouse is 
unaffected (Simmler et al., 2000). The roles of OTOGL and otolin are yet to be 
identified. 
Striated-sheet matrix is formed of two types of filaments, light-staining and dark-
staining, of about 7-9 nm in diameter (Hasko and Richardson, 1988). The composition 
of light and dark filaments is unclear. They may be homomeric, formed from either 
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alpha-tectorin or beta-tectorin, or heteromeric (Legan et al., 1997). Tectorins are also 
present in the covernet fibrils, the marginal band and Hensen’s stripe, denser structures 
within which there is no striated-sheet matrix. 
 
Figure 1.4. Organ of Corti and tectorial membrane structure (provided by R. Goodyear). 
1.4.2. Development of the tectorial membrane 
The first appearance of the TM in the mouse is observed by electron microscopy at 
embryonic day 16 (E16) as an amorphous substance, known as the primordial TM, over 
the greater epithelial ridge (GER) (Fig.1.5, a) (Lim and Rueda, 1992). As the primordial 
TM develops, it extends and thickens to form the major TM by E18 (Lim, 1987). The 
major TM covers the surface of the GER including the developing IHCs. A structure 
known as the minor TM is first observed by E19 (Lim and Rueda, 1992) and covers the 
lesser epithelial ridge and developing OHCs (Fig.1.5, b). At birth the minor TM is 
recognised as a covering sheet that attaches to the Hensen’s cells, the supporting cells 
behind the outermost row of the OHCs, and extends to the major TM (Lim and Rueda, 
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1992; Rueda et al., 1996). A loose subtectorial meshwork connects the supporting cells 
with the undersurface of the minor TM (Fig.1.5, c). 
Between the fifth and sixth postnatal days (P5 and P6) the GER recedes, forming the 
inner spiral sulcus (Rueda et al., 1996). During the next week of development, the major 
TM and minor TM fuse to form the tectorial membrane properly (Fig.1.5, c). This 
process is guided by marginal pillars, interim structures that exist between P6 and P14 
on the apical surface of the third row of Deiter’s cells, on the lateral edge of the organ of 
Corti (Rueda et al., 1996). As a result of the maturation of the organ of Corti the IHCs 
move inwards and their hair bundles become detached from the TM whilst the OHCs 
hair bundles remain imbedded in the TM (Rueda et al., 1996). 
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Figure 1.5. Schematic representations of the development of the tectorial membrane.  A - the 
primordial TM formation, b - the major TM and minor TM formation, c - fusion of the major TM 
and minor TM. Modified from Lim and Rueda, 1992. 
1.4.3. Function of the tectorial membrane 
The function of the TM is yet to be fully elucidated. However, the fact that mutations in 
its proteins lead to deafness underlines the importance of the TM in hearing. Mutations 
in the gene encoding collagen XI cause non-progressive autosomal dominant non-
syndromic hearing loss (ADNSHL) across the middle frequencies in American and 
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Dutch families (McGuirt et al., 1999). A moderate autosomal recessive non-syndromic 
hearing loss (ARNSHL) is described for subjects with mutations in the otogelin gene 
OTOG (Schraders et al., 2012) and the otogelin-like gene OTOGL (Yariz et al., 2012). 
Missense mutation in Ceacam16 gene leads to progressive ADNSHL with a late onset 
in an American family (Zheng et al., 2011). Mutations in Tecta gene are the most 
common reason of ADNSHL. They can, however, also lead to ARNSHL (Hildebrand et 
al., 2011). 
Data on Tecta
ΔENT/ΔENT
 mutant mice with a targeted deletion in Tecta gene indicate that 
the TM is a resonant structure that provides an inertial mass against which the OHCs 
react at the CF of the BM (Legan et al., 2000). The TM allows the OHCs to provide 
feedback to the BM with optimal gain and at the appropriate time in the BM motion 
cycle (Legan et al., 2000). It also plays an important role in activating IHCs by complex 
fluid movements in the subtectorial space that excite the hair bundles at the CF (Legan 
et al., 2005). As the BM, the TM is more narrow and stiff at its base is more wide and 
floppy at its apex (Freberg, 2009). It was shown that the TM is not a mechanically stiff 
structure, but possesses visco-elasticity and thus can support travelling waves (Abnet 
and Freeman, 2000). This travelling wave can stimulate hair cells and couple with the 
BM travelling wave to affect cochlear sensitivity and tuning (Ghaffari et al., 2007).  
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1.5. The components of the striated-sheet matrix of the tectorial 
membrane 
1.5.1. Tectorins   
1.5.1.1. Tecta and Tectb 
Tecta is a large modular glycoprotein of about 240 kDa with 33 potential N-
glycosylation sites (Legan et al, 1997). It has an entactin domain at its N-terminus, 
which is akin to the G1 domain of the basement membrane glycoprotein entactin, a 
central zonadhesin-like (ZA) domain which includes three full and two partial von 
Willebrand factor type C (vWFC V0) or D repeats (vWFD V1, V2, V3 and V4), a sole 
zona pellucida (ZP) domain located at the C-terminal region and three trypsin inhibitor 
like cysteine rich domains (TIL1, 2, 3) (Fig.1.6) (Hildebrand et al., 2011). Tectb is a 
much smaller glycoprotein, ~36 kDa, with 4 potential N-glycosylation sites (Legan et 
al., 1997). It contains a single ZP-domain (Fig.1.6). Both tectorins have a signal 
sequence for transit into the endoplasmic reticulum located at the N-terminus of the 
protein. 
Sequence data indicates that tectorins contain the glycosylphosphatidylinositol-anchor 
(GPI-anchor) located downstream of a tetrabasic furin-like cleavage site (Fig.1.6). The 
GPI-anchor is thought to target tectorins to the apical surface of the cochlear epithelium, 
where they can be released into the extracellular space by specific endoproteases (Legan 
et al., 1997). 
When run on a SDS-PAGE (sodium dodecyl sulphate polyacrylamide gel 
electrophoresis) gel under reducing conditions, native tectorins of the TM resolve as 
three broad bands: high, medium and low molecular mass (HMM, MMM and LMM) 
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tectorins of corresponding masses ~173, ~60 and ~45 kDa (Richardson et al., 1987). 
HMM, MMM and LMM tectorin products are mainly derived from proteolytic 
processing of the Tecta molecule (Killick and Richardson, 1997; Legan et al., 1997). 
However, the LMM tectorin fraction is also partly represented by Tectb (Legan et al., 
1997). Fig.1.7 indicates the possible cleavage pattern of Tecta protein. The predicted 
polypeptides generated after processing would have masses of ~34 (LMM), ~147 
(HMM) and ~47 kDa (MMM) (Legan et al., 1997). The difference between predicted 
masses and masses observed on SDS-PAGE gels under reducing conditions is likely to 
be due to glycosylation, and the broad nature of the bands due to glycosylation 
heterogeneity. 
Transient expression of tectorin-encoding plasmids in CL4 cells showed that tectorins 
are effectively targeted to the cell apical surface (Witteveen, 2008). However, when 
CL4 cells are transiently transfected with plasmids encoding tectorins with deleted GPI-
anchors, both tectorins are retained within the cell (Witteveen, 2008). Cells, transfected 
with full-length tectorin DNA, but treated with tunicamycin, an inhibitor of protein N-
glycosylation, also accumulate tectorins in the cytoplasm (Witteveen, 2008). These data 
indicate that both the GPI-anchor and the correct N-glycosylation are required for the 
apical targeting of the tectorins (Witteveen, 2008). 
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Figure 1.6. Schematic structure of Tecta and Tectb proteins. The N-terminal signal sequence and the 
C-terminal characteristic of GPI-anchored proteins are shown as black bars. The endoproteinase 
cleavage sites in Tecta and Tectb are labelled by arrows. ENT is the entactin domain. V0 (vWFC) is 
a partial von Willebrand factor C domain; V1, V2, V3 and V4 are von Willebrand factor D domains 
where V4 is a partial domain (Xia et al., 2010). TIL 1, 2 and 3 stand for Trypsin Inhibitor Like 
cysteine rich domain. ZP - zona pellucida domain, shown as a red rectangle. Regions with no 
significant homology to other proteins are depicted as dark violet bars. Modified from Hildebrand et 
al., 2011 and Goodyear and Richardson, 2002. 
 
Figure 1.7. Tecta cleavage sites that might result in HMM, MMM and LMM Tecta suggested by N-
terminal sequence obtained by Edman degradation. The predicted masses of polypeptides are shown 
above the arrows (Legan et al., 1997). 
The ZP domain found in both tectorins is a motif of ~260 amino acids with 8 
conservative cysteine residues involved in forming intrachain disulfide bonds (Bork and 
Sander, 1992). The ZP domain is a common sequence of various extracellular proteins 
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that are able to form filaments or matrices (Jovine et al., 2002). It is considered to be an 
element that enables proteins to polymerise (Jovine et al., 2002). The presence of a ZP 
domain in both Tecta and Tectb suggests that tectorins may either self-assemble as 
homomeric filaments or form heteromeric filaments via interactions between their 
respective ZP domains (Jovine et al., 2005; Legan et al., 1997). 
Alternative interactions between Tecta and Tectb might occur via the Tecta ZA domain 
(Legan et al., 1997). This domain contains vWFC and vWFD subunits  and is highly 
homologous to the sperm transmembrane protein zonadhesin (ZAN) which is 
responsible for sperm - zona pellucida binding (Lea et al., 2001). Even the order of vWF 
repeats in Tecta protein is the same as in the ZAN molecule. Sperm-egg binding is 
mediated by zona pellucida glycoproteins of an oocyte. The similarity with the sperm-
egg adhesion system suggests that tectorins might interact in a similar way, with the ZA 
domain of Tecta interacting with ZP domains of Tectb and/or other Tecta molecules 
(Legan et al., 1997). 
The presence of vicinal cysteines in vWFD subunits of Tecta might provide an 
alternative model of tectorin interactions. The vicinal cysteines are thought to have 
protein disulphide isomerase activity which enables them to form a disulphide bond 
between their side chains (Carugo et al., 2003). It is then possible that von Willebrand 
factors which contain D repeats form multimers due to disulfide bond formation 
between the vicinal cysteine residues. Thus Tecta might form homomeric filaments via 
its ZA domain and interact with Tectb via its ZP domain. There is, however, no 
evidence of Tecta multimers in the TM (Legan et al., 1997). 
The data on the Tectb knock-out mouse model (Russell et al., 2007) suggests a possible 
role of Tectb protein in striated-sheet matrix organisation. Striated-sheet matrix is 
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absent in these mice. Tecta protein is, however, able to form disorganised filaments 
within the TM body, suggesting that Tectb might act as a crosslinker between Tecta 
filaments. 
1.5.1.2. Tectorin expression pattern and timeline 
In situ hybridisation experiments reveal Tecta and Tectb mRNAs are expressed in the 
basal end of the developing mouse cochlea at E12.5 (Rau et al., 1999). The patch of 
developing epithelial cells expressing Tectb mRNA is smaller than the area expressing 
Tecta mRNA (Rau et al., 1999). At E14.5 tectorin mRNA expression spreads into all 
turns of the cochlear duct (Rau et al., 1999). The expression of tectorin mRNA in the 
basal end of the developing mouse cochlea, thus, foreshadows the differentiation of 
sensory hair cells which starts at E14.5 with inner hair cells (Munnamalai et al., 2012). 
The patterns of Tecta and Tectb expression visible from E14.5 develop from the base of 
the cochlea to the apex and include two bands of expression for Tecta and three 
narrower bands of expression for Tectb (Fig. 1.8) (Rau et al., 1999). Tecta mRNA 
expression is detected throughout the GER and in the inner phalangeal cells around 
IHCs. A narrow zone of Tecta expression is also found in the first two rows of Hensen’s 
cells adjacent to the third row of Deiter’s cells (Fig.1.8). Tectb expression is seen in a 
narrow region of the GER alongside the IHCs, in the inner and outer pillar cells and in 
the third row of the Deiter’s cells. Tectb is also detected in the first and second rows of 
Deiter’s cells in the apex of the cochlea at early postnatal stages of development (Rau et 
al., 1999). 
By P8, Tecta expression at the base of the cochlea stops and the levels of Tectb 
expression are reduced. Expression of both tectorin mRNAs almost entirely stops by 
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P15 (Rau et al., 1999). Tectorin proteins, however, are stable and survive throughout the 
life of the organism.  
 
Figure 1.8. Tecta and Tectb protein expression patterns, for explanations refer to the text. GER – 
greater epithelial ridge, IH – inner hair cell, O1, O2, and O3 – three rows of outer hair cells, IP – 
inner pillar cell, OP – outer pillar cell, D1, D2 and D3 – three rows of Deiter’s cells. Cells 
expressing tectorin mRNAs are shaded dark grey. Modified from Rau et al., 1999. 
1.5.1.3. Deafness-causing mutations in Tecta 
The Tecta gene, which encodes Tecta protein, contains 23 exons (Sagong et al., 2010). 
It was mapped to mouse chromosome 9 (Hughes et al., 1998) and to human 
chromosome 11q22 - q24 (Hughes et al., 1998; Verhoeven et al., 1997; Verhoeven et al., 
1998). Mutations in Tecta gene have been shown to be responsible for sensorineural 
nonsyndromic hearing loss. They can be inherited either in an autosomal dominant 
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fashion causing ADNSHL or in an autosomal recessive manner resulting in ARNSHL 
(Alasti et al., 2008; Meyer et al., 2007). Missense mutations in Tecta produce ADNSHL 
with a variety of phenotypes (Moreno-Pelayo et al., 2001; Sagong et al., 2010; 
Verhoeven et al., 1998). ARNSHL, in contrast, is caused by truncating mutations 
(nonsense, frameshift, splice site) and are characterised by a common phenotype - 
moderate to profound prelingual deafness with mid-frequencies most affected (Meyer et 
al., 2007; Naz et al., 2003). However, a spontaneous missense mutation in the mouse 
Tecta gene which is recessive has also been described (Moreno-Pelayo et al., 2008). 
As mentioned above, dominant missense mutations in Tecta result in different 
phenotypes depending on the domain and residue affected (Alloisio et al., 1999; Iwasaki 
et al., 2002; Meyer et al., 2007; Moreno-Pelayo et al., 2001; Plantinga et al., 2006; 
Sagong et al., 2010; Verhoeven et al., 1998) enabling potential genotype-phenotype 
correlations to be studied (Hildebrand et al., 2011). Some of these mutations are 
represented on Fig.1.9 along with the domain structure of Tecta. 
 
Figure 1.9. Tecta domains and the location of different deafness-causing missense mutations 
indicated by asterisks. V0-V4 – vWFC and vWFD repeats; TIL1, 2 and 3 - trypsin inhibitor like 
cysteine rich domains 1, 2 and 3; Ex 17-Ex 20 - exons encoding ZP domain. Modified from Moreno-
Pelayo et al., 2001 and Hildebrand et al., 2011.      
30 
 
A dominant missense mutation found in a French family is located in the Tecta ZA 
domain (Fig.1.9) with a cysteine in the vWfD4 subdomain replaced by a serine (C1619S) 
(Alloisio et al., 1999). A cysteine to glycine substitution (C1837G) in the ZP domain of 
Tecta (Fig.1.9) results in ADNSHL in a Spanish family (Moreno-Pelayo et al., 2001). In 
a Belgian family the deafness phenotype is possibly caused by one of the two amino 
acid substitutions in the ZP domain (Fig.1.9) - leucine 1820 is replaced by 
phenylalanine (L1820F) and glycine 1824 is replaced by aspartic acid (G1824D) 
(Verhoeven et al., 1998). A mutation found in an Austrian family is another ZP domain 
mutation (Fig.1.9) with the substitution of a tyrosine for cysteine (Y1870C) (Verhoeven 
et al., 1998). The Belgian and the Spanish mutations are located in exon 17 of Tecta, the 
Austrian mutation maps to exon 18. 
Four transgenic mice with dominant missense mutations in Tecta corresponding to the 
deafness-causing mutations in the French, Belgian, Spanish and Austrian families have 
been generated to understand how these mutations affect the assembly and function of 
the TM matrix (Coates, 2009; Legan et al., 2005).  
The phenotypes described for mice heterozygous for the Spanish and Belgian mutations 
were comparable. In both mouse models, striated-sheet matrix was severely disrupted 
but only in the sulcal region, the marginal band was reduced and displaced medially and 
the covernet consisted of convoluted fibrils forming a mesh-like pattern that did not 
merge with the marginal band (Coates, 2009). In transgenic mice heterozygous for the 
Austrian mutation the limbal zone of the TM was reduced in thickness and the Kimura’s 
membrane was detached from the main body of the TM. The marginal band and the 
Hensen’s stripe were missing (Legan et al., 2005). The sulcal region of the TM lacked 
striated-sheet matrix and contained disorganised collagen fibrils (Legan et al., 2005). It 
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is likely that mutations in the ZP domain of Tecta disturb its interactions with other TM 
proteins and prevent tectorin assembly into striated-sheet matrix (Iwasaki et al., 2002). 
The phenotype of mice heterozygous for the French mutation provides a different model 
of protein-protein interactions within the TM with a much less disrupted striated-sheet 
matrix. The covernet is hardly distinguishable but still consists of the rod-like fibrils 
albeit of much finer diameter whilst the marginal band is fragmented (Coates, 2009). It 
is possible that a vicinal cysteine substitution by serine in the vWfD4 repeat changes 
Tecta assembly and cross-linking by affecting disulphide bond formation within the 
Tecta polypeptide (Iwasaki et al., 2002; Pfister et al., 2004).  
Two missense mutations affecting the cysteine compliment within the Tecta ZP domain 
were chosen to study protein-protein interactions and filament assembly in this research: 
the Spanish mutation where a cysteine is replaced and the Austrian mutation where a 
new cysteine is introduced. 
1.5.2. Ceacam16 
1.5.2.1. General information about Ceacam16 protein 
The carcinoembrionic antigen-related cell adhesion molecule (Ceacam) gene family 
(Kuespert et al., 2006) which includes the Ceacam16 gene belongs to the 
immunoglobulin superfamily of cell adhesion molecules (IgCAM) (Hammarstrom, 
1999; Kuespert et al., 2006). Ceacam proteins, which have so far only been discovered 
in mammals (Beauchemin et al., 1999), are characterised by the presence of at least one 
immunoglobulin (Ig)-like domain, and their genes are clustered on human chromosome 
19 (Hammarstrom, 1999; Kuespert et al., 2006). The Ig-like domain consists of 85-110 
amino acids (Kuespert et al., 2006) and has a characteristic structure which is referred to 
as an Ig fold (Barclay, 1999) or a “Greek key” (Vaughn and Bjorkman, 1996). The Ig 
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fold is made of seven to nine antiparallel β-strands arranged in two sheets (Barclay, 
1999; Brooks, 2009; Halaby et al., 1999). On the basis of structural and sequence 
variations, the Ig fold domains have been subdivided into three groups: Ig variable (IgV) 
domain, Ig constant (IgC) type 1 domain  and IgC type 2 domain (Kuespert et al., 2006; 
Vaughn and Bjorkman, 1996). IgV-like domain contains nine β-strands which are more 
variable in sequence (Brooks, 2009). The smaller IgC-like domain consists of seven β-
strands, and the two sheets they form are connected via highly conservative disulfide 
bonds. There is some minor variation in β-strand organisation between IgC1 and IgC2-
like domains (Vaughn and Bjorkman, 1996). The functions of Ceacam proteins include 
cell-cell interactions, tissue homeostasis, angiogenesis and tumorigenesis and, in 
addition, they can act as pathogen receptors (Benchimol et al., 1989; Hammarstrom, 
1999; Hauck et al., 2006; Horst et al., 2006; Kuespert et al., 2006).  
Ceacam16 is a secreted glycoprotein with a signal peptide at its NH2-terminus and a 
proteolytic cleavage site between the 23
rd
 and 24
th
 amino acids. There are no predicted 
transmembrane domains or a GPI-anchor (Zheng et al., 2011). It consists of two IgV-
like, or N, domains flanking two IgC2-like domains in the middle (Fig.1.10) (Zebhauser 
et al., 2005; Zheng et al., 2011). Ceacam16 protein has 7 cysteines, 7 potential N-
glycosylation sites (Fig.1.10) and there is only one known splice variant (Zheng et al., 
2011). Transient transfection of HEK293 cells with a construct encoding Ceacam16 and 
a subsequent western blotting analysis suggests that Ceacam16 is secreted in the form of 
disulfide cross-linked dimers and tetramers (Zheng et al., 2011).     
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Figure 1.10. Schematic representation of the domain structure of Ceacam16 protein. N1 is an NH2-
terminal IgV-like domain, N2 is an COOH-terminal IgV-like domain. A and B are IgC2-like 
domains of subtype A and B. SS depicts highly conservative disulfide bridges in the IgC2-like 
domains. Pins represent potential N-glycosylation sites. Adapted from Zebhauser et al., 2005.  
1.5.2.2. Ceacam16 in the inner ear 
In the mouse cochlea, expression of Ceacam16 mRNA is detected from E17 and lasts at 
least until P42 (Zheng et al., 2011). In situ hybridisation experiments suggested that 
Ceacam16 is expressed in OHCs, but not in IHCs or supporting cells (Zheng et al., 
2011). Confocal microscopy suggested that the Ceacam16 protein expression located to 
the tips of OHC stereocilia. In addition, a strong anti-Ceacam16 labelling was detected 
in the main body of the TM, indicating that Ceacam16 is a component of this region 
(Zheng et al., 2011).  
Finally, co-immunoprecipitation studies suggested that Ceacam16 protein might bind to 
Tecta in the TM and it was proposed that it would act as a component of attachment 
crowns linking the tips of OHC stereocilia to the TM (Zheng et al., 2011). 
1.5.2.3. Ceacam16 gene and human deafness DFNA4 
The Ceacam16 gene is highly conserved among mice, rats and humans (Zebhauser et al., 
2005). In humans, it locates to chromosome 19q13.31 (Zheng et al., 2011). DFNA4 
hearing loss detected in an American family maps to the same locus (Chen et al., 1995) 
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suggesting Ceacam16 as a candidate gene for this type of deafness. Individuals affected 
by DFNA4 develop a severe-to-profound hearing loss across all frequencies with an 
onset in early adolescence and a deficit of up to 50 dB in adulthood (Chen et al., 1995). 
More recent studies have shown that DFNA4 hearing impairment is caused by a T140P 
(threonine to proline replacement) mutation in the Ceacam16 gene which disrupts a 
highly conserved N-glycosylation site (Zheng et al., 2011). This might alter protein 
folding and, therefore, cause its degradation or instability (Zheng et al., 2011).    
1.6. Aims of the thesis 
Little is known about how the striated-sheet matrix develops. It is unclear how Tecta 
and Tectb proteins are secreted, processed and assembled and how deafness-causing 
mutations in Tecta could interrupt these processes. The recently described Ceacam16 
protein might also be involved in the striated-sheet matrix assembly and could maintain 
its stability over the life time (Zheng et al., 2011). These problems set the aims of this 
thesis which can be formulated as follows: 
1. The first aim is to create an in vitro model for studying the assembly of the TM 
matrix with an ultimate purpose to investigate how it is disrupted by the known 
Tecta deafness mutations. 
2. The second aim of this study is to elucidate the role of Ceacam16 protein in 
normal hearing by creating a Ceacam16 functional null mouse model and 
describing its phenotype. 
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CHAPTER 2 
Materials and Methods 
2.1. Gene cloning techniques 
The process of gene cloning is used to create recombinant DNA molecules containing 
genes of interest and to achieve their replication within the host. 
2.1.1. Polymerase chain reaction 
Polymerase chain reaction (PCR) is used to amplify the DNA sequence of interest. 
2.1.1.1. Amplification of PCR products for cloning 
Pfu turbo DNA polymerase (Stratagene), an enzyme with a “proof reading” activity, 
was used to amplify inserts for ligation into plasmid constructs. A typical PCR reaction 
mixture was set up in a volume of 25 µl, its content is presented in a Table 2.1 (Insert 
amplification column). A standard PCR program used a heated lid and included 
following steps:  
1. initial denaturation at 94oC for 2 min 
2. denaturation at 94oC for 15 sec      
3. annealing at 55oC for 15 sec  
4. extension at 72oC, 1 min per 1 kb 
5. final extension at 72oC for 5 min 
Steps 2 to 4 were usually repeated for 25 times. However, the annealing temperature 
and the number of cycles were varied to increase the yield of the product.  
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Amplified inserts were then gel purified to remove template and unincorporated dNTPs 
and primers (2.1.5).  
To join two PCR products, A and B, in one PCR reaction, both were PCR amplified and 
gel purified (2.1.5). Both PCR products (100 ng each) were added to a Pfu reaction mix 
and amplified with a forward primer for A and a reverse primer for B as described 
above. Joined product was gel purified (2.1.5). 
2.1.1.2. Mutagenic PCR 
Stratagene QuickChange site-directed mutagenesis method was used to introduce point 
mutations into vectors. The technique utilises PCR with the Pfu turbo DNA polymerase 
(Agilent) and requires a special primer design. Forward and reverse mutagenic primers 
were made as complementary to each other oligonucleotides with the desired mutation 
flanked by 10-15 bases of correct sequence on each side. A PCR mixture set up in a 
volume of 50 µl included components as in the Table 2.1 (Mutagenic PCR column): 
1. initial denaturation at 94oC for 2 min 
2. denaturation at 94oC for 15 sec 
3. annealing at 50oC for 15 sec 
4. extension at 68oC, 1 kb in one min 
5. final extension at 68oC for 5 min 
Steps 2 to 4 were repeated for 12 times. Although the annealing temperature could be 
varied, the number of cycles was kept quite low to minimise the chance of DNA 
polymerase errors. 
To digest the parental DNA template a DpnI restriction enzyme that only cleaves at 
methylated sites was used. 2 µl of DpnI were added to the PCR reaction.  It was 
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incubated at 37
o
C for 2 hours and the desired product was gel purified (2.1.5) and 
transformed into XL1 Blue competent cells (Stratagene) (2.1.8). 
Reagents Insert amplification Mutagenic PCR 
10x cloned Pfu reaction 
buffer (Stratagene) 
2.5 µl 5 µl 
10 mM deoxynucleotide 
triphosphates (dNTPs) 
(Promega) 
0.5 µl 1 µl 
25 pmol/µl forward primer 0.5 µl 1 µl 
25 pmol/µl reverse primer 0.5 µl 1 µl 
Template 100 ng 50 ng 
Pfu turbo DNA 
polymerase (Agilent) 
1.25 units 2.5 units 
Sterile H2O To 25 µl To 50 µl 
Table 2.1. PCR mixture content for insert amplification and mutagenic PCR. 
2.1.1.3. AccuPrime PCR 
AccuPrime Taq DNA polymerase High Fidelity (Invitrogen) was used to amplify large 
DNA fragments used to create targeting vectors and in case when Pfu polymerase failed 
to produce a satisfactory product. The following components were used in an 
AccuPrime reaction mixture: 
Reagents Amount used 
10x AccuPrime PCR buffer I (Invitrogen) 5 µl 
25 pmol/µl forward primer 1 µl 
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25 pmol/µl reverse primer 1 µl 
Template 10 ng 
AccuPrime Taq High Fidelity 0.2 µl 
Sterile H2O To 50 µl 
Table 2.2. PCR mixture content for AccuPrime PCR. 
The PCR program used was similar to the mutagenic PCR program. The number of 
cycles used was varied between 25 and 35. The amplification product was analysed by 
TBE agarose gel electrophoresis (1.4) or gel purified if used for cloning (1.5).  
2.1.1.4. PCR for In-Fusion cloning 
DNA fragments for In-Fusion cloning (Clontech) were amplified with either Pfu turbo 
DNA polymerase (Stratagene) or AccuPrime Taq DNA polymerase High Fidelity 
(Invitrogen) as described in sections 2.1.1.1 and 2.1.1.3. The In-Fusion cloning 
technique allows joining of DNA fragments which have a 15-base overlap (Fig.2.1). 
This overlap is introduced by PCR with appropriately designed primers. A typical 
primer for in-fusion cloning has a 15-base overlap at its 5’ end with the end of the DNA 
fragment it was meant to be joined. The 3’ end is gene-specific to the target fragment 
sequence. 
The PCR products were digested with DpnI and separated on a Tris-borate EDTA 
(TBE) agarose gel. The DNA was gel purified (2.1.5) and used in In-fusion cloning 
reactions (2.1.7). 
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Figure 2.1. Directional cloning of a DNA fragment into a linearised vector. DNA fragment of 
interest was amplified with specially designed primers which contain 15 bp overlaps with the ends of 
the linearised vector. 
2.1.1.5. PCR screening of bacterial colonies 
PCR screening was used to determine the presence of the desired insert in transformed 
bacterial colonies. Single colonies were picked with autoclaved toothpicks, transferred 
to an LB agar master plate containing the appropriate antibiotic, and then dipped into a 
well of the PCR plate (BIOplastics) containing 25 µl of the PCR reaction mix. PCR 
mixture for one well included 2.5 µl of 10x NH4 reaction buffer (Bioline), 0.75 µl of 50 
mM MgCl2 (Bioline), 0.5 µl of 10 mM dNTPs (Promega), 0.5 µl of forward and the 
same amount of reverse primers (both primers at working concentration 25 pmol/µl), 
20.15 µl of sterile H2O and 0.1 µl of BIOTAQ DNA polymerase (Bioline). 2 drops of 
mineral oil were added to each well of the plate to prevent evaporation of the mixture 
during cycling. A plate was then placed in the thermocycler. A typical PCR program 
has an initial denaturation at 94
o
C for 2 min followed by 25 cycles of denaturation at 
94
o
C 15 sec, annealing at 52
o
C for 15 sec and extension at 72
o
C 1 min for 1 kb. The 
annealing temperature and number of cycles, however, could be changed in some cases 
depending on primer sequences and yield of a product. A final extension at 72
o
C lasted 
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for 5 min. Heated lid was used during cycling. Samples were then cooled down to 4
o
C, 
separated on 0.7 % TBE agarose gels, stained with ethidium bromide and photographed 
under UV light (2.1.4). 
The master plate was incubated on 37
o
C overnight. Colonies positive by PCR were 
inoculated into 5 ml of LB medium with the appropriate antibiotic to obtain an 
overnight culture for plasmid minipreparation.   
2.1.1.6. PCR clean-up 
The NucleoSpin Extract II (Marchery-Nagel) was used to remove traces of primers, 
salts, enzymes and nucleotides from a PCR product. One volume of sample was mixed 
with two volumes of binding buffer (buffer NT). If the sample was less than 100 µl it 
was first made to 100 µl with buffer NT.  
The mixture was loaded onto a NucleoSpin Extract II column, placed into a collection 
tube and centrifuged for one minute at 13,000 rpm. The flow-through was discarded and 
the column was washed with 700 µl of buffer NT3 by centrifugation for 1 min at 13,000 
rpm. The flow-through was discarded and the column was centrifuged for 2 min at 
13,000 rpm to remove the residual buffer NT3. DNA was eluted in 20-50 µl of elution 
buffer (buffer NE). To collect the eluate the column was incubated at room temperature 
for 1 min and then centrifuged for 1 min at 13,000 rpm.  
2.1.2. DNA digestion with restriction enzymes 
All digestion reactions were performed with NEB restriction endonucleases (New 
England BioLabs Inc.) in 50 µl of reaction mixture for PCR products and in 20 µl for 
vectors. DNA digests with two enzymes (double digests) were performed 
simultaneously, in one reaction tube, with a NEBuffer (New England BioLabs Inc.) in 
which both enzymes had the most activity. Ten units of an appropriate restriction 
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endonuclease were used per 1 µg of DNA. The typical digestion reaction mixture 
contained following components: 
Reagents 20 µl reaction volume 50 µl reaction volume 
Appropriate 10x NEBuffer 
(supplied by NEB with 
enzymes) 
2 µl 5 µl 
10x bovine serum albumin 
(BSA) if required (NEB) 
2 µl 5 µl 
Restriction enzyme (NEB) 0.5 µl – 1 µl 0.5 µl – 1 µl 
DNA  0.5 µg – 1 µg 0.5 µg – 1 µg 
Sterile H2O to 20 µl to 50 µl 
Table 2.3. Restriction endonuclease digestion reaction mixtures.  
Digestion reactions were set up in microcentrifuge tubes, briefly centrifuged at 13,000 
rpm and incubated on 37
o
C for 1 hour.  
2.1.3. Dephosphorylation 
Vector re-circularisation during ligation reactions (2.1.6) was prevented by 
dephosphorylation of vector DNA with alkaline phosphatase to remove 5’ phosphates 
from both ends of the linearised vector DNA.  
One tenth of a volume of 10x Antarctic phosphatase reaction buffer (NEB) and 1 µl (5 
units) of Antarctic phosphatase were added to the tube with cut DNA after the 
restriction endonuclease reaction was finished. The tube was then incubated at 37
o
C for 
15 min. Afterwards another 5 units of enzyme were added to the mixture and it was 
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incubated at 37
o
C for additional 15 min. The phosphatase was heat inactivated at 65
o
C 
for 5 min. Dephosphorylated vector DNA was then gel purified (2.1.5). 
2.1.4. DNA gel electrophoresis 
DNA was separated on horizontal slab 0.7 % agarose, 1x TBE gel. 1x TBE, used as 
electrophoresis buffer, contained 89 mM Tris base, 88 mM orthoboric acid and 2 mM 
EDTA. Agarose (BioGene Ltd) was dissolved in 1x TBE buffer and melted in a 
microwave oven. DNA samples were mixed with 0.1 vols of 10x loading dye (50 % 
glycerol, 1 mM Tris-HCl, pH 8.0, 0.25 % w/v bromophenol blue and 1 mM EDTA). 
One or two lanes of either 100 bp or 1 kb (depending on DNA fragment analysed) DNA 
size marker were run adjacent to sample lanes. Electrophoresis was performed in 1x 
TBE buffer. DNA on small gels was separated at constant voltage 100 V for 30 min, on 
big gels - at 220 V for 30 min. 
Gels were then incubated in 0.5 µg/ml ethidium bromide in H2O for 30 min. Preparative 
gels were incubated for 40 min. DNA bands were visualised on a UV (ultraviolet) 
transilluminator. Analytical gels were photographed with a CCD camera coupled to a 
thermal printer. Preparative gels were visualised on a long wavelength UV 
transilluminator and DNA bands of interest were excised for purification. 
2.1.5. DNA purification from TBE agarose gels 
The NucleoSpin Extract II kit (Macherey-Nagel) was used to extract DNA separated on 
1x TBE agarose gels as described in 2.1.4. The DNA fragment of interest was excised 
from the agarose gel with a clean scalpel. The gel slice was weighted and mixed with 2 
volumes of binding buffer (buffer NT). The mixture was incubated at 50
o
C for 10-15 
min with intermittent vortexing until the agarose slice was fully dissolved. A 
NucleoSpin Extract II column was placed into 2 ml collection tube. The sample was 
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loaded on the column and centrifuged for 1 min at 13,000 rpm. The flow-through was 
discarded. The column was then washed with 700 µl of wash buffer (buffer NT3) with 
added ethanol. The sample was then centrifuged 1 min at 13,000 rpm and the flow-
through was discarded. The column was centrifuged for 2 min at 13,000 rpm to remove 
the residual buffer NT3. The column was then placed into a clean microcentrifuge tube. 
Elution buffer (buffer NE) was added to the column, 20 µl for vectors and 50 µl for 
inserts. The column was incubated for 1 min at room temperature to increase the yield 
of DNA and then centrifuged for 1 min at 13,000 rpm to collect the eluate. Eluate (2 µl) 
was loaded onto an analytical 1x TBE agarose gel to confirm recovery of the desired 
band. 
2.1.6. Ligation 
Vector and insert digested with the one restriction enzyme on the 5’ end and a different 
enzyme on the 3’ end to generate compatible overhangs and gel purified were joined 
together in a ligation reaction. Vector and insert DNA were used in 1:3 molar ratio. In 
addition, a tube with a double concentration of insert was set up. Ligation was carried 
out in four reactions referred as no ligase (-L), with ligase (+L), insert and ligase (+I+L) 
and double amount of insert with the same amount of enzyme (+I1+L). –L and +L 
reactions contained only vector without insert and were used as a control. A typical 
ligation mixture included: 
Components -L +L +I+L (+I1+L 
10x ligase buffer 
(NEB)  
1 µl 1 µl 1 µl 1 µl 
Sterile H2O  8 µl 8 µl 4 µl - 
Linearised vector 1 µl 1 µl 1 µl 1 µl 
44 
 
Insert - - 4 µl 8 µl 
T4 DNA ligase (NEB) - 0.5 µl 0.5 µl 0.5 µl 
Table 2.4. The composition of ligation reactions. 
The reactions were incubated at 14
o
C in a cold water bath overnight. Next day all four 
reactions were transformed into competent E. coli cells. 
2.1.7. In-fusion cloning 
The In-Fusion HD cloning kit (Clontech) was used for fast precise cloning of PCR 
products without using restriction enzymes and DNA ligase. PCR reactions for In-
Fusion cloning were set up as described in 2.1.1.4. PCR products were digested with 
DpnI and gel purified to use in the In-Fusion cloning reaction. A typical In-Fusion 
cloning reaction was set up in a 10 µl volume and contained 50 ng of vector, an 
equimolar amount of insert and 2 µl of 5x In-Fusion HD enzyme premix (Clontech). 
Negative control mixtures were carried out without In-fusion HD enzyme premix and 
without insert. Both reactions were incubated at 50
o
C for 15 minutes, placed on ice and 
transformed into competent bacterial cells (2.1.8). 
2.1.8. Bacterial transformation 
2.1.8.1. Bacterial culture medium 
Lysogeny broth, or LB medium, created by Bertrani, is a nutrient-rich medium used for 
growing bacterial cultures. It was prepared by adding 10 g of tryptone (Oxoid), 5 g of 
yeast extract (Oxoid) and 10 g of NaCl (Fisher chemical) to 950 ml of water. The pH 
was adjusted to 7.0 with 1 N NaOH and the volume was then made to 1 L. LB was 
autoclaved in Boxer 200/25LE benchtop autoclave at 121
o
C. The whole cycle including 
warming up and cooling down takes about two hours.  
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To make LB agar plates containing selective antibiotics, 15 g of bacto agar (BD) was 
added to 1 L of LB and the mixture was autoclaved as described above. Afterwards the 
bottle was cooled down to 47
o
C in a water bath and the appropriate selective antibiotic 
was added (Table 2.5). The bottle was swirled to mix in the antibiotic and the agar was 
poured into 90 mm petri dishes. 
Selective antibiotic Concentration 
Ampicillin 50 µg/ml 
Kanamycin 25 µg/ml 
Table 2.5. Selective antibiotics and their concentration. 
Super-optimal broth with catabolite repression (SOC medium) is a modification of LB 
for increased plasmid transformation efficiency. To prepare SOC medium 20 g of 
tryptone, 5 g of yeast extract, 0.58 g of NaCl, 0.186g of KCl (Fisons) and 0.952 g of 
MgCl2 (Fisher Scientific) were added to 800 ml of water. The solution was mixed and 
made up to 980 ml with water once all the components were dissolved. SOC medium 
was autoclaved as described above. Once it was cooled down, 20 ml of filter-sterilized 1 
M glucose was added. SOC medium was then aliquoted into 15 ml tubes (Cellstar) and 
stored at room temperature.  
2.1.8.2. Bacterial transformation 
DNA (ligation reactions, in-fusion cloning, mutagenic PCR products and plasmid 
minipreps) was transformed into chemically competent XL1 Blue cells (Stratagene) 
following the manufacturer instructions. 
One vial (250 µl) of XL1 Blue competent cells from -80
o
C was thawed on ice. For the 
transformation of ligation reactions two vials of XL1 Blue competent cells were used. 
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When thawed, cells were gently mixed and 100 µl were aliquoted in pre-chilled falcon 
tubes. 1.7 µl of β-mercaptoethanol were added to each aliquot and the mixture was 
swirled. Cells were incubated on ice for 10 min and swirled every 2 min. Afterwards 2 
µl of the DNA containing mixture were added to the cells. The tubes were swirled and 
left on ice for 30 min. Meanwhile, the water bath and SOC medium were preheated to 
42
o
C. The cells were then heat-pulsed in the 42
o
C water bath for 45 sec and incubated 
on ice for 2 min. 900 µl of SOC medium were added to each falcon tube and they were 
incubated at 37
o
C shaking at 250 rpm for one hour. Afterwards each transformation 
reaction was plated on a labelled LB agar plate with an appropriate antibiotic in aliquots 
of 200 µl, 100 µl and 50 µl. Plates were incubated at 37
o
C overnight. On the next day 
colonies were screened by PCR or set up as overnight cultures in LB with an 
appropriate antibiotic (Table 2.5) for the plasmid minipreparation. 
2.1.9. DNA preparation 
2.1.9.1. Plasmid minipreparation 
Overnight cultures were prepared by introducing single bacterial colonies into 50 ml 
tubes (Cellstar) containing 5 ml of sterile LB supplemented with the appropriate 
antibiotic (Table 2.5). Cultures were grown at 37
o
C shaking at 250 rpm overnight. 
Plasmid DNA was prepared using NucleoSpin plasmid DNA purification kit 
(Macherey-Nagel). Bacterial cells were pelleted from 3 ml of cell suspension in a 
benchtop centrifuge (accuSpin Micro, Fisher Scientific) by sequential 1 min spins at 
13,000 rpm in microcentrifuge tubes. The remaining culture (2 ml) was used for 
preparing glycerol stocks (2.1.9.4) and inoculating a culture for plasmid 
maxipreparation. The supernatant was discarded and cell pellets were re-suspended in 
250 µl of resuspension buffer (buffer A1) by pipetting up and down. 250 µl of lysis 
buffer (buffer A2) were added to each tube. Tubes were gently inverted 6-8 times to mix 
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the contents and then incubated for 5 min at room temperature. 300 µl of neutralisation 
buffer (buffer A3) was added to each tube, the contents were mixed by inverting the 
tubes 6-8 times and clarified by the centrifugation for 5 min in a benchtop centrifuge at 
13,000 rpm. The clear supernatant was then transferred to a NucleoSpin Plasmid 
column placed in the collection tube and centrifuged for 1 min at 13,000 rpm. The flow-
through was discarded, and 600 µl of wash buffer (buffer A4) containing ethanol were 
added to the column. The spin column was then centrifuged for 1 min at 13,000 rpm 
and the flow-through was discarded. The spin column was centrifuged again for 2 min 
at 13,000 rpm to remove traces of the wash buffer. The NucleoSpin Plasmid column 
was then placed into a clean microcentrifuge tube and 50 µl of elution buffer (buffer 
AE) were added. The columns were incubated at room temperature for 5 min and the 
eluate was collected by centrifugation for 1 min at 13,000 rpm. Concentrations of the 
eluted plasmids were measured (2.1.9.3). 
2.1.9.2. Plasmid maxipreparation 
Plasmid maxipreparation was performed using NucleoBond Xtra Maxi kit (Macherey-
Nagel). 250 ml of LB with the appropriate antibiotic (Table 2.5) were inoculated with 2-
5 ml of a starter bacterial culture and grown overnight (12-16 hours) at 37
o
C with 
shaking at 250 rpm. The cells were pelleted by centrifugation for 10 min at 4
o
C using a 
Sorvall GSA rotor (Dupont) at 5000 rpm. The supernatant was discarded and the cell 
pellet was resuspended in 12 ml of resuspension buffer (buffer RES) plus RNase A in a 
concentration of 60 µg/ml by pipetting up and down. When no clumps were detected in 
the suspension, 12 ml of lysis buffer (buffer LYS) were added. The tube was gently 
inverted 5 times and incubated at room temperature for 5 min. Meanwhile, a 
NucleoBond Xtra column was equilibrated by applying 25 ml of buffer EQU to the rim 
of the column filter so that the filter was thoroughly wetted. The bacterial lysate was 
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neutralised with 12 ml of neutralisation buffer (buffer NEU), mixed by gently inverting 
the tube 10-15 times and the lysate was loaded onto the column. The column filter was 
then washed with 15 ml of buffer EQU applied to the rim of the filter to wash out the 
remaining lysate. The column filter was then discarded and the column was washed 
with 25 ml of wash buffer (buffer WASH). The DNA was eluted with 15 ml of elution 
buffer (buffer ELU) and collected in an Oakridge tube. To precipitate the eluate, 10.5 
ml of room-temperature isopropanol were added to it. The tube was vortexed and then 
centrifuged at 15,000 g for 30 min at 4
o
C using a Sorvall SS-34 rotor (Dupont). The 
supernatant was discarded, the pellet was washed with 5 ml of 70 % ethanol and 
centrifuged at 15,000 g for 5 min at room temperature. Supernatant was then carefully 
discarded and the pellet was dried at room temperature for 15 min. The dry pellet was 
dissolved in 500 µl of buffer TE (10 mM Tris-HCl, 1 mM EDTA, pH 8.0). DNA 
concentration was measured with a Picodrop spectrophotometer (2.1.9.3). 
2.1.9.3. DNA concentration measurement 
DNA concentration was measured using a Picodrop spectrophotometer. The amount of 
DNA in a solution was quantified at 260 nm using the fact that the concentration of 
double stranded DNA in a 10 mm pathlength cell with OD260 of 1.0 equals 50 µg/ml.  
The purity of the DNA sample was assessed by the ratio of absorbance at 260 nm to 280 
nm. Pure DNA preparations had a value of 1.8. 
2.1.9.4. Glycerol stocks 
Clones of the constructs made were maintained as glycerol stocks at -80
o
C. Bacterial 
cells were harvested from 5 ml overnight cultures. 800 µl of cell suspension were mixed 
with 200µl of sterile 80 % glycerol in an microcentrifuge tube and then frozen at -80
o
C.  
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2.1.10. Cloning procedures 
Vector DNA was obtained by plasmid minipreparation (2.1.9.1). DNA prepared by 
plasmid maxipreparation (2.1.9.2) was used as well after being diluted to a 
concentration of 10 – 50 ng/µl. The insert DNA was either cut out of a plasmid by 
restriction enzyme digest (2.1.2) or amplified by one of the PCR techniques mentioned 
above (2.1.1). The vector and the insert were then digested with the same restriction 
enzymes (2.1.2) and the vector DNA was dephosphorylated (2.1.3). Both DNAs were 
separated on a preparative 0.7 % TBE agarose gel (2.1.4), purified as described in 2.1.5 
and ligated 2.1.6.  
Basic steps for In-fusion cloning are described in 2.1.7. 
Ligation and In-Fusion reactions were transformed into chemically competent E. coli 
XL1 Blue cells (2.1.8). The transformed colonies were screened either by colony PCR 
(2.1.1.5) or by sequencing. Clones containing the desired construct were used to make 5 
ml overnight cultures. These cultures were used for DNA minipreparation. Extracted 
plasmid DNAs were either screened by sequencing or, in the case of PCR screening, 
digested with appropriate restriction endonucleases to confirm the size of the insert. 
Plasmid DNA from at least one positive clone was fully sequenced to confirm the 
orientation of the insert and to check that no unwanted mutations were introduced. 
Positive clones were stored as glycerol stocks at -80
o
C (2.1.9.4). Plasmid 
maxipreparations were used to obtain a large amount of mammalian expression vector 
DNA. DNA was stored at -20
o
C. 
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2.2. Cell culture techniques 
2.2.1. Basic cell culture procedures 
Cell culture procedures were performed in a laminar flow hood under sterile conditions. 
Madin-Darby canine kidney cells (MDCK) and human embryonic kidney 293 cells 
(HEK 293) were cultured in a Dulbecco’s Modified Eagle’s Medium (DMEM) (Sigma) 
supplemented with 10 % of fetal bovine serum (FBS) “Gold” (PAA), 20 mM L-
glutamine (GibCo) and 20 mM penicillin/streptomycin (GibCo). Human colonic 
adenocarcinoma cells (CaCo2) were grown in DMEM supplemented with 20 % of FBS, 
20 mM L-glutamine and 20 mM penicillin/streptomycin. To recover either of these 
three cell lines from liquid N2 stocks, a cryovial, containing frozen cells, was quickly 
removed from liquid nitrogen and immediately placed into 37
o
C water bath. Once 
thawed, cells were transferred to a 15 ml centrifuge tube containing 10 ml of a pre-
warmed growth medium. The tube was gently inverted to re-suspend the cells and 
centrifuged for 5 min on 300 g in the accuSpin 400 centrifuge (Fischer Scientific). 
Supernatant was aspirated and the cell pellet was re-suspended in 5 ml of pre-warmed 
culture medium and transferred to a 75 cm
2
 flask (Nunc) with 20 ml of culture medium 
in it. Cells were incubated in a humidified 5 % CO2 incubator at 37
o
C and their viability 
was assessed next day under the inverted microscope (diavert Leitz Wetzlar).  
To prevent the exhaustion of nutrients in the medium, cells were passaged when they 
were about 70 % confluent, usually every five days. Cells were washed twice with 
sterile PBS (1x PBS contains 150 mM NaCl and 10 mM sodium phosphate, pH 7.4) to 
remove serum and 2 ml of trypsin/EDTA (Sigma) were added to the flask. The flask 
was gently shaken to distribute trypsin/EDTA over the cell monolayer and returned to 
the 37
o
C incubator. MDCK and CaCo2 cells were incubated for 10 min and HEK 293 
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cells for 5 min only. To ensure that cells were completely detached from each other and 
from the culture surface, they were examined using the inverted microscope. Cells were 
then re-suspended in 8 ml of appropriate medium to inactivate trypsin. If cell number 
was required, a 20 µl of cell sample was applied to a counting slide (Fast Read 102 ISL) 
and cells were counted. The required amount of cell suspension was then transferred to 
a new cell culture flask containing growth medium. The remainder of the cell 
suspension was centrifuged for 5 min at 300 g in the accuSpin 400 centrifuge (Fischer 
Scientific), the supernatant was aspirated and the cell pellet was stored at – 20oC and 
used for antibody preabsorption when needed. 
Cells from early passages were frozen down and kept as a seed stock in liquid nitrogen. 
Cells were washed in PBS, trypsinised and re-suspended in growth medium as 
described above. They were then centrifuged for 5 min at 300 g. The supernatant was 
discarded and the cell pellet was re-suspended in pre-chilled growth medium containing 
10 % dimethyl sulfoxide (DMSO) (Sigma). The cell suspension was then split into 
cryovials (Greiner Bio-One), 1 ml into each. Cryovials were placed in a penoplast box 
and transferred to -20
o
C for 2 hours, then to -80
o
C overnight and, finally, into liquid 
nitrogen tanks. 
2.2.2. Cell transfection 
The day before a transfection, cells were plated into 35 mm polystyrene petri dishes 
(Corning) either on sterile glass coverslips (if used for immunofluorescence) or directly 
into the dish (if used for western blot or stable cell line generation). On the day of 
transfection cells were 70-80 % confluent. In the morning, cells were fed with a medium 
without penicillin/streptomycin. Lipofectamine 2000 (Invitrogen) was used as the 
transfection reagent. The mass/volume ratio of DNA and lipofectamine 2000 was kept 
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at 1:5, using 4 µg plasmid DNA and 20 µl lipofectamine 2000 per dish. In the case of 
co-transfection with two different DNAs, 2 µg of each plasmid were used. To make the 
transfection mix, 20 µl of lipofectamine 2000 were added to 230 µl of OptiMEM. The 
plasmid DNA (4 µg) was diluted to 250 µl with Opti-MEM (GibCo). Both mixtures 
were incubated at room temperature for 5 min and then mixed together by pipetting. 
The mixture was incubated at room temperature for 20 min to form DNA-lipofectamine 
2000 complexes and then added to 2.5 ml of growth medium without 
penicillin/streptomycin. The medium in transfection dishes was replaced with medium, 
containing DNA-lipofectamine complexes and cells were incubated in the humidified 5 
% CO2 incubator at 37
o
C for 1 or 2 days. 
2.3. Protein analysis 
2.3.1. Sample preparation 
Transiently or stably transfected cells expressing the protein of interest were plated in 
35 mm polysterene petri dishes (Corning) and incubated at 37
o
C until 70-80 % 
confluency was reached (usually 24 hours). Afterwards the medium was aspirated, cells 
were washed 3 times with PBS and incubated in 1 ml serum-free medium for two days. 
The medium was then harvested into clean microcentrifuge tubes and cell monolayers 
were washed 3 times with PBS. Cells were scraped off the dishes with a sterile tip, 
washed off with 1 ml of PBS and transferred into clean microcentrifuge tubes. Both 
medium and cell samples were centrifuged at 14,500 rpm for 5 min at 4
o
C using a 
miniSpin
plus
 centrifuge (Eppendorf).  
900 µl of the supernatant from the media samples were collected in fresh 
microcentrifuge tubes and trichloracetic acid (TCA) precipitated. One volume of 100 % 
TCA (Fluka) was added to nine volumes of supernatant. Samples were then incubated 
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on ice for 30 min and centrifuged at 4
o
C on 14,500 rpm for 3 min in the miniSpin
plus
 
centrifuge (Eppendorf). The supernatant was then discarded, and pellets were washed 
twice with IMS (Industrial methylated spirit), dried at room temperature and mixed with 
30 µl of 1x non-reducing sample buffer (125 mM Tris, pH 6.8, 2 % SDS, 10 % glycerol 
(Sigma), 0.1 % bromophenol blue and sterile H2O to 1 ml). To make a 1x reducing 
sample buffer 5 % of β-mercaptoethanol and 0.1 M DTT (dithiothreitol) were added to 
the mixture. 
Supernatant from cell samples was discarded and cell pellets were mixed with 50 µl of 
1x reducing or non-reducing sample buffer. 
All samples were heated at 104
o
C for 4 min, mixed by pipetting and centrifuged for 1 
min at 13,000 rpm to get rid of air bubbles.    
2.3.2. Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
Vertical SDS-PAGE gels were prepared using the BioRad mini-format gel system. The 
two gel plates were washed with 70 % ethanol and dried before use, clamped together 
and then placed in the gel pouring stand. A 5 cm-high resolving gel (Table 2.6) was 
poured by pipetting the mix between the plates and covered with a layer of water-
saturated n-butanol to stop O2 mediated inhibition of polymerisation. Once the resolving 
gel was polymerised, the n-butanol was discarded and any remaining drops removed 
using Whatman 3 MM paper. A stacking gel mixture (Table 2.7) was then poured on 
top of the resolving gel. A plastic comb was inserted between the plates to form wells in 
the stacking gel. Stacking gel was allowed to polymerise. 
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Components 7.5 % resolving gel 10 % resolving gel 
Acrylamide 1 ml 1.33 ml 
4x separation buffer 
(1.5 M Tris-HCl pH 8.8, 0.4 
% SDS)  
1 ml 1 ml 
Ammonium persulphate 
(APS) 5 mg/ml 
0.4 ml 0.4 ml 
Sterile H2O 1.6 ml 1.27 ml 
Tetramethylethylenediamine 
(TEMED) 
5 µl 5 µl 
Table 2.6. Composition of 7.5 % and 10 % resolving gel solutions. 
Components Stacking gel 
Sterile H2O 1.1 ml 
Acrylamide 0.2 ml 
APS 5 mg/ml 0.2 ml 
4x stacking buffer 
(0.5 M Tris-HCl pH 6.8, 0.4 % SDS) 
0.5 ml 
TEMED 5 µl 
Table 2.7. Composition of stacking gel solution. 
The gel plates were then clamped into the electrode assembly and placed in the 
electrophoresis tank. Two gel cassettes were usually mounted on the electrode assembly 
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to create the running buffer chamber. When only one gel cassette was used, a thick 
plastic blanking plate was mounted instead of the second gel plate. 
1x SDS-PAGE running buffer (25 mM Tris, 192 mM glycine and 0.1% SDS) was 
poured between the gel plates to cover the sample wells and into the electrophoresis 
tank to one fourth of its level. The comb was carefully removed and samples were 
loaded into the wells. 5 µl of protein molecular weight marker Precision Plus Protein 
Standards Dual Color (BioRad) were loaded in at least one well on each gel. 
Electrophoresis was carried out at 20 mA (constant current) for one gel and 40 mA for 
two gels for about 1 hour. 
2.3.3. Semi-dry western blotting and protein detection 
Proteins separated on SDS-PAGE gels were transferred onto Hybond-P PVDF 
membrane (Amersham) by semi-dry blotting. For each gel, ten pieces of Whatman 3 
MM paper 10 cm x 8 cm were prepared. While the gel was running, three sheets of 
paper were soaked in anode buffer I (300 mM Tris base, 20 % methanol, pH 10.4), two 
sheets - in anode buffer II (25 mM Tris base, 20 % methanol, pH 10.4) and five sheets - 
in cathode buffer (25 mM Tris base, 40 mM 6-amino-n-hexanoic acid, 20 % methanol, 
pH 9.4). 10 x 8 cm PVDF membrane was wetted in methanol and then soaked in anode 
buffer II.  
Once the loading buffer ran off the bottom of the gel, the transfer was set up: the three 
sheets of Whatman 3MM, soaked in anode buffer I, were placed on the anodal plate of 
the blotter and a 10 ml glass pipette was rolled on top of the wetted paper stack to 
remove trapped bubbles. Two sheets from anode buffer II were then placed on top of the 
stack and the procedure with the glass pipette was repeated. After excessive buffer was 
drained off, the PVDF membrane was layered on top of the 3 MM paper stack and the 
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resolving gel was carefully aligned on its surface. The gel was covered with five 
cathode buffer-soaked Whatman sheets, ensuring no bubbles were trapped between 
them, and the cathode plate of the blotter was placed on top without disturbing the 
stack. The transfer was set up at 40 mA (constant current) for one gel and 80 mA for 
two gels for 1 hour. 
After 1 hour the blotting apparatus was disassembled and the PVDF membrane was 
incubated in blocking solution for 1 hour on a shaker at room temperature. Blocking 
solution contains 3 % of skimmed milk powder in TBS-t (150 mM NaCl, 10 mM Tris-
HCl, pH 7.4, 0.2 % Tween-20). After 1 hour the blocking solution was replaced with a 
primary antibody against the protein of interest diluted in blocking solution and the 
membrane was probed overnight on a shaker at 4
o
C. 
Sometimes to eliminate non-specific binding activity of a primary antibody, it was 
preabsorped on a frozen cell pellet (2.2.1) before use. Cell pellet was thawed at room 
temperature and washed three times in PBS. During each washing it was rotated for 5 
min at room temperature and then centrifuged for 5 min on 300 g in the accuSpin 400 
centrifuge (Fischer Scientific). The primary antibody was diluted to the desired 
concentration in 1-4 ml of PBS, added to the washed cell pellet, mixed by vortexing and 
rotated for 2 hours at room temperature. The preabsorbed antibody preparation was then 
centrifuged for 5 min at 300 g to pellet the cell debris and used for probing the PVDF 
membrane at 4
o
C on a shaker overnight. 
Next day the membrane was washed three times in TBS-t, each wash lasted for 10 min. 
The washes were followed by staining with an alkaline phosphatase-conjugated 
secondary antibody (DAKO), raised against the IgG of species which produced the 
primary antibody. The secondary antibody was used at a concentration of 1 vol in 1000 
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vols of blocking solution and the incubation was performed for 2 hours on a shaker at 
room temperature. Afterwards, the membrane was given three 10-minute washes in 
TBS-t and two 10-minute washes in TBS. During the last wash an alkaline phosphatase 
buffer (AP buffer) was prepared (Table 2.8). BCIP, which produces an insoluble purple-
blue product in the presence of alkaline phosphatase, and NBT, which intensifies the 
colour and increases the sensitivity, were added to the AP buffer immediately before 
use. The blot was incubated in AP buffer for approximately 10 min, until the colour had 
developed sufficiently. The membrane was when washed several times in deionised 
water and dried on paper towels. 
Component Amount needed to prepare 10 ml of AP 
buffer 
1 M MgCl2 0.5 ml 
1 M Tris-HCl pH 9.5 1 ml 
4 M NaCl 0.25 ml 
Sterile H2O 8.25 ml 
5-bromo-4-chloro-3-indolyl phosphate 
(BCIP) 
10 µl 
Nitro-blue tetrazolium chloride (NBT) 10 µl 
Table 2.8. Composition of AP buffer. 
2.4. Immunofluorescence 
2.4.1. Paraformaldehyde fixation 
Specimens (coverslips with cells, murine cochleae and cochlear cultures) were washed 
three times with PBS and fixed with 3.7 % formaldehyde in 0.1 M sodium phosphate 
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buffer, pH 7.4, for 1 hour at room temperature. Afterwards, fixed specimens were 
washed three times in PBS to remove the excess paraformaldehyde.  
2.4.2. Cryosectioning 
For fine microscopic analysis of complex tissues and anatomical structures, frozen 
sections were obtained from the fixed specimens. Bony structures, i.e. cochleae, 
required an additional step of decalcification in 0.5 M EDTA, pH 8.0, for 2-4 days, 
depending on the age of the animal. Older cochleae required prolonged incubation in 
EDTA. For any age the EDTA solution was always changed on the second day. The day 
before cryosectioning the specimens were placed in 30% sucrose (Fisher Scientific) in 
PBS and stored on 4
o
C overnight. Next morning the specimens were embedded in 
cryoagar (1 % type 7 low geling temperature agar (Sigma-Aldrich) added to 18 % 
sucrose in PBS) poured into a 35 mm polystyrene petri dish, using a dissection 
microscope (Zeiss Stemi 2000) to visualise the tissue pieces. The cryoagar was allowed 
to set at room temperature for about 10 min and then placed at 4
o
C for half an hour. The 
block with the specimens was cut out when the cryoagar became solid, instantly frozen 
with cryospray 134 (TAAB) and mounted on a metal base with optimal cutting 
temperature (OCT) compound (Tissue-Tek). Sections (15-20 µm thick) were taken 
using a Cryocut 1800 microtome (Reichert-Jung) at -30
o
C. Sections were collected on 
glass slides (Thermo-Scientific) coated with 0.5 % gelatin (BDH Chemicals Ltd), dried 
in a 37
o
C incubator overnight and then placed at -20
o
C for storage. 
2.4.3. Immunostaining 
Prepared frozen sections (cell coverslips or cochlear cultures) were incubated in 
blocking solution (10 % Horse Serum in PBS) for 1 hour at room temperature. When 
detecting intracellular proteins in cells and cochlear cultures, they were permeabilised 
59 
 
by adding 0.1 % of Triton X-100 to the blocking solution. The blocking solution was 
then aspirated. A slide with sections was then rinsed with PBS (coverslips with cells and 
cochlear cultures were washed in a petri dish). Primary antibodies were diluted as 
required in 10 % Horse Serum in PBS and were added to the sections. Sections were 
then incubated overnight in a humid chamber at room temperature (coverslips with cells 
and cochlear cultures were incubated overnight on a rocker at 4
o
C). On the next day the 
slides were washed three times in PBS. The secondary antibodies against the IgG of 
species that were the source of the primary antibody were diluted in 10 % Horse Serum 
in PBS and centrifuged for 5 min at 13,000 rpm at room temperature. The supernatant 
was carefully collected to avoid pellets and added to the specimens. Sometimes Texas 
Red®-X conjugated phalloidin at the dilution of 1:500 (Molecular Probes, Invitrogen) 
or fluorescein phalloidin in the dilution of 1:500 (Molecular Probes, Invitrogen) were 
used as a counter-stain by adding to the secondary antibody solution. The slides were 
incubated for 2 hours at room temperature either on a rocker (cell coverslips and 
cochlear cultures) or in a humid chamber (sections). They were then washed three times 
in PBS and mounted using Vectashield (Vector Laboratories) mounting medium. The 
specimens were examined by wide-field fluorescence microscopy (Zeiss Axioplan 2) 
and/or by confocal microscopy (Zeiss LSM S10). 
2.5. Transmission and scanning electron microscopy techniques 
Specimens were fixed, washed and incubated with a primary antibody as described in 
2.4.1 and 2.4.3. The specimens were then washed five times with 1 % Horse Serum in 
PBS, 5 min each wash. Gold-conjugated secondary antibodies, specific for the IgG of 
the species which produced the primary antibody, were used to identify surface antigens 
by transmission electron microscopy (TEM) and scanning electron microscopy (SEM). 
To distinguish two secondary antibodies in the case of double-labelling with two 
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different primary antibodies, each secondary antibody was conjugated to a different size 
of a gold particle. Gold-conjugated secondary antibodies were purchased from Abcam® 
and were used at a dilution of 1:10 in 10 % Horse Serum, 1 mM EDTA, pH 8.0, 0.05 % 
Tween-20 and 0.1 mM in PBS. The specimens were incubated with the gold-conjugated 
secondary antibodies for 48 hours on a rocker at 4
o
C and then given three 5-minute 
washes with 0.05 % Tween® 20 in PBS and two 5-minute washed in PBS only.  
The specimens were then fixed in glutaraldehyde fixative (2.5 % glutaraldehyde, 0.1 M 
sodium cacodylate in sterile H2O) for 2 hours. If the specimens were prepared for TEM, 
1 % tannic acid (Sigma-Aldrich) was added to the fixative to enhance the electron 
density of protein filaments. After fixation, specimens were given three 5-minute 
washes in 0.1 M sodium cacodylate. 
Specimens were then re-fixed with 1 % osmium tetroxide in 0.1 M sodium cacodylate 
for 1 hour. They were then washed three times with 0.1 M sodium cacodylate, rinsed 
with sterile water and dehydrated by using a graded series of ethanol. The specimens 
were first treated with 50 % ethanol, then sequentially transferred into 70 %, 80 % and 
90 % ethanol. Each step lasted not more than 5 min to prevent the shrinkage of the 
tissue. Finally, the specimens were transferred to absolute ethanol for 10 min. This step 
was repeated two more times.  
The samples for SEM were then placed into labeled porous plastic pots in 100 % 
ethanol and critical point dried to dry the tissue with preserving it 3D structure in a 
special apparatus. They were then mounted on aluminum stubs with silver paint. Carbon 
coating was performed with a Balzers BAF 400D freeze-fracture device. Carbon was 
evaporated from an electron beam gun at 90
o 
with sample rotation for 10-15 sec. 
Samples were then examined with a Jeol 6400 cold field emission scanning electron 
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microscope. Acceleration voltage was set up at 5 kV, an emission current at 10 mA and 
a probe current at 10 pA. Images were captured with different detection modes. The 
secondary electron image (SEI) mode was used for high-resolution pictures of a sample 
surface. The backscatter detector (BSD) was utilized for images of the gold labeling. 
Images were also captured in the Add-mode, which combines the SEI and the BSD. 
The specimens for TEM were infiltrated in epoxy resin (Epon) (TAAB) with 100% 
ethanol mixed in a ratio of 1:1 for 1 hour at room temperature. They were then 
incubated in 3:1 Epon with 100% ethanol for 3 hours at room temperature. Finally, the 
specimens were transferred into pure Epon and incubated overnight at room 
temperature. On the next day the samples were moved into embedding molds containing 
pure Epon and incubated at 70
o
C for 48 hours. Special polyethylene capsules, 
containing a piece of paper with a label, were filled with Epon and placed into 70
o
C 
oven as well. Once the Epon was solid, the block with embedded specimen was 
extracted from the mold and glued onto the Epon-filled capsule that further served as a 
holder. The block was then filed and trimmed to make it easier to section. 1 µm sections 
were taken using an Ultracut E microtome (Reichert-Jung). They were stained with 
toluidine blue and examined on a Zeiss Axioplan 2 microscope. If the region of interest 
was present on 1 µm sections, sections of 90-100 nm thickness were taken using the 
same microtome and the diamond knife (TAAB). The sections were mounted on copper 
grids and stained with uranyl acetate for 30 min. They were then washed three times in 
sterile water and stained with lead citrate for 8 min. Afterwards the sections were given 
four washes with sterile water and dried. A Hitachi 7100 transmission electron 
microscope was used for examining sections. Images were captured with a Gatan 
Ultrascan 1000 CCD camera.  
62 
 
2.6. X-gal staining of mouse cochleae 
Animals were killed by cervical dislocation. Cochleae were extracted and placed in PBS 
for dissection. The oval and round windows were removed and a small hole was made 
in the bony capsule and stria vascularis at the apex of each cochlea. 
Cochleae were transferred to cold X-gal fixative (1 % formaldehyde, 0.25 % 
glutaraldehyde, 2 mM MgCl2, 5 mM EGTA, 0.02 % NP-40 in 1x PBS) and fixed for 2 
hours on ice. To prepare X-gal fixative 270 µl of 37 % formaldehyde (Sigma-Aldrich), 
100 µl of 25 % glutaraldehyde (TAAB), 20 µl of 1 M MgCl2, 250 µl of 200 mM EGTA, 
20 µl of 10 % NP-40, 1000 µl of 10x PBS were diluted with sterile water to 10 ml. 
After fixation, cochleae were washed three times in room-temperature PBS. They were 
then transferred into 35 mm petri dishes each containing 3 ml of X-gal solution. X-gal 
solution was prepared according to the Table 2.9. 
Reagent Amount 
Potassium ferricyanide 82.25 mg 
Potassium ferrocyanide 105.5 mg 
10 % sodium deoxycholate 50 µl 
10 % NP-40 100 µl 
1 M MgCl2 100 µl 
50 mg/ml X-gal (Melford Laboratories 
ltd) in dimethylformamide (Sigma) 
1 ml 
10x PBS 5 ml 
Sterile H2O To 50 ml 
Table 2.9. Composition of XGal solution. 
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Dishes with cochleae were stored in the dark at 4
o
C for 5 days. On day 3 the X-gal 
solution was replaced with fresh solution. On the fifth day cochleae were washed three 
times in 0.02 % NP-40 in PBS, re-fixed in cold X-gal fixative for 2 hours on ice and 
washed three times with 0.02 % NP-40 in PBS again. Cochleae were then decalcified 
and cryosectioned as described in 4.2. 
2.7. Materials and methods used for creating an in vitro model of the 
tectorial membrane 
2.7.1. Vector design 
2.7.1.1. pBK-Tecta-IRES-TurboFP635 construct 
The internal ribosome entry site (IRES) was amplified using Pfu polymerase enzyme 
(Stratagene) (2.1.1.1) from pIRES2-EGFP bicistronic vector (Clontech) (Fig.2.2). The 
polymerase chain reaction (PCR) reaction was set-up with following primers (Table 
2.10): TectaIRES-F1 was designed to join the 3’ end of the Tecta open reading frame 
(ORF) with the 5’ end of the IRES via a XhoI restriction site, and IRESturboFP635-R1 
was made to join the 3’ end of the IRES and the 5’ end of the TurboFP635-N vector 
(Evrogen, Moscow, Russian Federation). Vector TurboFP635-N encodes far-red 
fluorescent protein TurboFP635 (Fig.2.3). The TurboFP635 ORF was amplified with 
Pfu polymerase and following primers (Table 2.10): IRESturboFP635-F1 which joins 
the 3’ end of IRES ORF with the 5’ end of TurboFP635 and TurboFP635-R1 designed 
to fuse the 3’ end of TurboFP635, via an XhoI restriction site, with the SV40 
polyadenylation signal of a plasmid pBK-Tecta-FL7 containing a full length Tecta ORF 
(pBK stands for plasmid backbone). 
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Figure 2.2. pIRES2-EGFP vector map (Clontech). The IRES sequence (584 bp) is located between 
the multiple cloning site (MCS) and the enchanced green fluorescent protein (EGFP) coding region. 
P CMV IE is the human cytomegalovirus immediate early promoter. SV40 poly A - the SV40 early 
mRNA polyadenylation signal is followed by the f1 single-strand DNA origin (f1 ori). The next is a 
bacterial promoter for expression of Kan
r
 gene. SV40 ori is the SV40 origin of replication, P SV40 e 
- SV40 early promoter/enhancer. Kan
r
/Neo
r
 stands for the kanamycin/neomycin resistance gene. 
HSV TK poly A is herpes simplex virus thymidine kinase polyadenylation signal. pUC ori - pUC 
plasmid replication origin (from BD Biosciences Clontech information sheet).   
65 
 
 
Figure 2.3. pTurboFP635-N vector map (Evrogen). The structure of the vector is similar to that of 
pIRES2-EGFP from Clontech. TurboFP635 ORF is located between MCS and SV40 early mRNA 
polyadenylation signal (from Evrogen data sheet). 
The IRES and the TurboFP635 were amplified, mixed together and joined by PCR as 
described in 2.1.1.1 using Pfu polymerase and primers TectaIRES-F1 and TurboFP635-
R1 (Table 2.10). The joined product was then digested with XhoI enzyme (2.1.2) and 
ligated (2.1.6) into the Tecta expression vector, pBK-Tecta-FL7 (Fig.2.4), which was 
also digested with XhoI and dephosphorylated (2.1.3). The ligation reaction was 
transformed into XL1 Blue competent cells and plated on LB plates containing 
kanamycin (2.1.8). Clones were screened using PCR (2.1.1.5) and the orientation of the 
insert was confirmed by restriction digestion of DNA mini preparations (2.1.9.1). One 
of the clones, pBK_Tecta_IRES_TurboFP635_23, was confirmed to be correct by DNA 
sequencing. Maxi-prepped plasmid (2.1.9.2) was used for mammalian cell transfection 
experiments. Fig.2.5, a, gives the schematic representation of the 
Tecta_IRES_TurboFP635 insert. 
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Figure 2.4. pBK-TectaFL7 vector, schematic representation. The full length Tecta ORF is located at 
the position 612 - 7065, between the MCS and the SV40 early mRNA polyadenylation signal. The 
abbreviations are as used above (Fig.2.1 and Fig.2.2). 
2.7.1.2. pBK-mCherry-Tecta construct 
Vector pBK-mCherry-Tecta encodes Tecta protein which is tagged with the mCherry 
fluorophore at its N-terminus (Fig.2.5, b). mCherry protein was selected due to its 
photostability and bright colour that makes it easy to trace during live imaging 
experiments. The Tecta signal peptide sequence was amplified from pBK-TectaFL7 
construct (Fig.2.4) by PCR with Pfu enzyme and the following primers (Table 2.10): 
pBKTecta-F1 which joins the 5’ end of the Tecta signal sequence to the plasmid 
backbone downstream from the CMV immediate early promoter and pBKChryTecta-R1 
which joins the 3’ end of the Tecta signal sequence and the 5’ end of the mCherry ORF.  
mCherry was amplified from the construct pBK-Tecta-mCherry which is similar to 
pBK-Tecta-IRES-TurboFP635 (Fig.2.5, a) with an IRES driving mCherry transcription. 
The PCR was set up with Pfu Taq and the primers (Table 2.10) pBKChryTecta-F1 and 
pBKChryTecta-R2. The first primer joins the 5’ end of mCherry to 3’ end of a Tecta 
signal peptide sequence, the latter fuses the 3’ end of mCherry to the 5’ end of Tecta 
ORF. The first 264 bp of Tecta ORF were amplified with Pfu polymerase and the 
primer pair: pBKChryTecta-F2 and pBKTecta-R3 (Table 2.10).  
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The three PCR products were then mixed and joined by PCR with Pfu polymerase and 
primers pBKTecta-F1 and pBKTecta-R3. The joined product was then digested with 
NheI and EcoRI and ligated into pBK-TectaFL7 backbone that had been cut with NheI 
and EcoRI and dephosphorylated.  
2.7.1.3. Introducing deletions into the pBK-mCherry-Tecta construct 
2.7.1.3.1. pBK-mCherry-MMMTecta construct 
A construct containing mCherry fused in frame with MMM Tecta (Fig.1.7 for MMM 
Tecta, which is a part of the fourth vWFD repeat along with the ZP domain) was 
generated using the In-fusion cloning technique (2.1.7). First, a PCR reaction to amplify 
a required fragment from pBK-mCherry-Tecta was set up using Pfu Taq polymerase 
and primers ChTectaMMM-F that primes to the 5’ end of the MMMTecta sequence and 
ChTectaMMM-R2 that anneals to mCherry ORF 3’ end (Table 2.10). These primers 
amplify the plasmid backbone containing only mCherry and MMM Tecta thus 
introducing a deletion of LMM and HMM Tecta. 100 ng of the product were then used 
in the In-fusion cloning reaction.  
2.7.1.3.2. pBK-mCherry-ZPTecta construct 
pBK-mCherry-Tecta construct was modified so that C-terminus of mCherry became 
fused directly to the Tecta ZP domain (Fig.1.6). Entactin and ZA domains were both 
completely deleted. The deletion was introduced using In-fusion cloning approach. The 
plasmid backbone containing mCherry and ZP domain of Tecta was amplified with 
primers ChTectaDD-F that anneals to the 5’ end of Tecta ZP domain and ChTectaDD-
R2 that primes with the 3’ end of mCherry ORF (Table 2.10). These primers amplify 
the plasmid backbone containing only mCherry and Tecta ZP domain. 100 ng of PCR 
product was added to an In-fusion cloning reaction. 
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2.7.1.4. pBK-EGFP-Tecta construct 
pBK-EGFP-Tecta construct contains EGFP N-terminally fused to the Tecta ORF 
downstream from the Tecta signal peptide sequence (Fig.2.5, c). 
EGFP was amplified from pBK-EGFP-Tectb construct described below using primers 
Tecta-EGFP and EGFP-Tecta (Table 2.10). Plasmid backbone was amplified from 
pBK-mCherry-Tecta construct (Fig.2.5, b) so that the mCherry coding sequence was 
excluded with primers TectamCherryt2EGFP-F and TectamCherry2EGFP-R (Table 
2.10). 50 ng of each PCR product were used in the In-Fusion reaction. 
2.7.1.5. pBK-EGFP-Tectb construct 
pBK-EGFP-Tectb vector (Fig.2.5, d), encoding N-terminally EGFP-tagged Tectb 
protein, was designed to assess Tectb expression levels and localisation using live 
fluorescence imaging. The EGFP gene is located downstream of the Tectb signal 
sequence, and the 3’ end of the EGFP ORF is fused in frame to 5’ end of the Tectb ORF 
via the multiple cloning site (MCS). The expression of EGFP-Tectb fusion protein is 
driven by CMV immediate early promoter. 
2.7.1.6. Introducing missense mutations for Tecta into Tectb 
Mutations in ZP domain of Tecta protein, causing deafness in humans, were introduced 
into ZP domain of the Tectb protein. Tectb protein residues synonymous to those 
substituted in mutant forms of Tecta were identified by protein sequence alignment. The 
ZP modules of human Tecta and mouse Tectb proteins were aligned with other 
members of ZP protein family from a range of animal species using the ClustalV 
algorithm in DNASTAR MegAlign software (Lasergene). 
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2.7.1.6.1. C1837G (Spanish) mutation  
The synonymous cysteine was replaced by glycine in mouse Tectb and transiently 
expressed in mammalian cells in vitro. The missense mutation that results in amino acid 
substitution was introduced in pBK-EGFP-Tectb construct by PCR site directed 
mutagenesis (2.1.1.2) using turbo Pfu polymerase. Mutagenic primers were designed to 
replace the first thymine in TGT codon by guanine which results in cysteine substitution 
with glycine (Table 2.10): TectbC59G-F1 and TectbC59G-R1. 
2.7.1.6.2. Y1870C (Austrian) mutation 
The conserved tyrosine residue in the ZP domain of mouse Tectb synonymous to human 
Tecta tyrosine 1870 was replaced by cysteine. An appropriate missense mutation 
changing A in TAC codon by G was introduced in pBK-EGFP-Tectb by PCR site 
directed mutagenesis with primers TectbC61T-F1 and TectbC61T-R1 (Table 2.10). 
 
Figure 2.5. Inserts of the constructs generated in this work. A - pBK-Tecta-IRES-turboFP635, b - 
pBK-mCherry-Tecta, c - pBK-EGFP-Tecta, d - pBK-EGFP-Tectb, e - pCAG-mCherry-Tecta, f - 
pCAG-EGFP-Tectb. P CMV ie - CMV immediate early promoter, CAG - CAG promoter. Pink box 
between the promoter and the fluorescent protein in b, c and e stands for a Tecta signal peptide 
sequence. Blue bar downstream the promoter and upstream the EGFP sequence on d and f is a Tectb 
signal peptide sequence. Yellow box between the EGFP and the Tectb ORF stands for polylinker.  
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2.7.1.7. pCAG constructs 
2.7.1.7.1. pCAG-mCherry-Tecta construct 
Vector pCAG-EGFP (Fig.2.6) was a kind gift from Dr. Marcelo Rivolta, University of 
Sheffield, UK. pCAG-EGFP is a bicistronic construct with a CAG promoter driving 
EGFP and an IRES to express the puromycin resistance gene. CAG is a strong promoter 
obtained by connecting the CMV-IE enhancer sequence with AG , chicken βactin/rabbit 
β-globin hybrid promoter (Miyazaki et al., 1989; Niwa et al., 1991)  
The vector was digested with XhoI and NotI restriction enzymes to remove EGFP ORF 
from the construct and dephosphorylated. A polylinker (Fig.2.7) was inserted into the 
digested plasmid backbone to introduce several new restriction sites. The polylinker 
was made from primers described in Table 2.10. pCAGlinker-F fuses with 3’ sticky end 
of pCAG-EGFP which results from XhoI digest. Once ligated in the construct the 
primer destroys XhoI restriction site. pCAGlinker-R fuses to 5’ end of NotI digested 
pCAG-EGFP and destroys the NotI restriction site. 
 
Figure 2.6. pCAG-EGFP vector map. Puro-r is puromycin resistance gene. bGHpa stands for the 
bovine growth hormone polyadenylation signal. ColE1 ori rep is E. coli ColE1 origin of replication 
site. AmpR is gene encoding bacterial ampicillin resistance (the map was kindly provided by Dr. 
Rivolta, University of Sheffield).    
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Figure 2.7. A polylinker which replaced EGFP in pCAG-EGFP construct. 
Both primers were synthesized with 5’ phosphate to enable ligation in the construct and 
annealed leaving protruding ends at both 5’ and 3’ sides. The annealing reaction used 1 
µg of each primer, 5 µl of 10x ligation buffer (New England BioSciences) and sterile 
H2O to 50 µl of volume. The mixture was incubated at 85
o
C for 10 min and allowed to 
cool down to room temperature. The annealed oligonucleotides were then ligated into 
digested and dephosphorylated plasmid backbone.  
pCAG plasmid backbone containing polylinker was digested with NheI and XhoI 
restriction enzymes and dephosphorylated. The mCherry-Tecta fusion was cut out from 
pBK-mCherry-Tecta construct with NheI and XhoI and ligated in pCAG backbone. The 
clones were screened by PCR and then by digestion of miniprepped DNA. Positive 
clone pCAG-mCherry-Tecta23 was re-confirmed by sequencing and a maxipreparation 
of the DNA was made. For schematic representation of mCherry-Tecta insert 
downstream the CAG promoter see Fig.2.5, e. 
2.7.1.7.2. pCAG-EGFP-Tectb construct 
The EGFP-Tectb fusion was amplified from the pBK-EGFP-Tectb construct using 
AccuPrime Taq DNA polymerase (2.1.1.3) and the following primers: PBK-F1 which 
anneals to the CMV immediate early promoter and the NheI restriction site between 
CMV immediate early and EGFP sequence, and mmTectbSal which introduces a SalI 
restriction site and a MluI restriction site at the 3’ end of the EGFP-Tectb fragment 
(Table 2.10). SalI enzyme produces a sticky end which is compatible with XhoI cut 
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DNA. As ligation of SalI end and XhoI end eliminates both restriction sites, the primer 
introduces a MluI restriction site in case further cloning manipulations are required.  
The PCR product EGFP-Tectb-SalI-MluI was digested with NheI and SalI restriction 
enzymes and the vector pCAG-polylinker was cut with NheI and XhoI and then 
dephosphorylated. The resultant DNA fragments were then ligated. Figure 2.5, f 
schematically represents the EGFP_Tectb insert in pCAG backbone. 
Primer name Primer sequence 
from the 5’ end to 
the 3’ end 
Construct they 
were used to 
make 
Positions and special features 
TectaIRES-F1  CCTCATAACTC
GAGATCCGC 
pBK-Tecta-
IRES-
turboFP635 
1-8 - complementary to the 
Tecta ORF 
15-20 - to the IRES ORF 
XhoI restriction site is 
underlined 
IRESturboFP6
35-R1  
ACGCTATCCTC
ACCCACCATG
GTTGTGGCCAT
ATTATC 
pBK-Tecta-
IRES-
turboFP635 
1-23 - complementary to 
TurboFP635 ORF 
 24-38 - to IRES ORF 
IRESturboFP6
35-F1 
GATAATATGG
CCACAACCAT
GGTGGGTGAG
GATAGCGT 
pBK-Tecta-
IRES-
turboFP635 
Reverse complement to 
IRESturboFP635-R1 
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TurboFP635-
R1 
TGAGCTCGAG
TCAGTTATTCA
GCTGTGCCCCA
GTTTGC 
pBK-Tecta-
IRES-
turboFP635 
1-14 - SV40 polyadenylation 
signal 
15-24 - TurboFP635 ORF 
XhoI site is underlined 
pBKTecta-F1 GCTAGCCACC
ATGAATTATTC
ATCATTACTTA
G 
pBK-mCherry-
Tecta 
1-10 - CMV immediate early 
promoter 
11-33 - complement to the Tecta 
signal peptide sequence 
pBKChryTect
a-R1 
CAAGCTCAGC
CCAGGGAGCT
CATGGTGAGC
AAGGGCGAGG
AG 
pBK-mCherry-
Tecta 
1-21 - complementary to 
mCherry ORF 
22-42 - Tecta signal peptide 
sequence 
pBKChryTect
a-F1 
CAAGCTCAGC
CCAGGGAGCT
CATGGTGAGC
AAGGGCGAGG
AG 
pBK-mCherry-
Tecta 
Reverse complement to the 
pBKmChryTecta-R1 
pBKChryTect
a-R2 
GTCATTCTGCC
AAAATGGATA
CATCTTGTACA
GCTCGTCCATG
C 
pBK-mCherry-
Tecta 
1-24 - Tecta ORF 
25-44 - mCherry ORF 
 GCATGGACGA pBK-mCherry- Reverse complement sequence 
74 
 
pBKChryTect
a-F2 
GCTGTACAAG
ATGTATCCATT
TTGGCAGAAT
GAC 
Tecta to pBKChryTecta-R2 
pBKTecta-R3 TTCTCTGTAAT
AGATCTCAC 
pBK-mCherry-
Tecta 
Complementary to Tecta ORF 
sequence in the middle of exon 
3 
ChTectaMM
M-F 
AGCTGCAACG
AGCTACAGTT 
pBK-mCherry-
MMMTecta 
Complementary to the 5’ end of  
MMMTecta coding sequence 
ChTectaMM
M-R2 
TAGCTCGTTGC
AGCTCTTGTAC
AGCTCGTCCAT
G 
pBK-mCherry-
MMMTecta 
1-18 - the 3’ end of mCherry 
ORF 
19-34 - complementary to 
ChTectaMMM-F 
ChTectaDD-F ACCTGCAAGG
CAGCCCAGAT
G 
pBK-mCherry-
ZPTecta 
Complementary to the 5’ end of 
Tecta ZP domain 
ChTectaDD-
R2 
GGCTGCCTTGC
AGGTCTTGTAC
AGCTCGTCCAT
G 
pBK-mCherry-
ZPTecta 
1-15 - overlap with ChTectaDD-
F primer  
16-34 - complementary to the 3’ 
end of mCherry ORF 
Tecta-EGFP CAGCCCAGGG
AGCTCGTGAG
CAAGGGCGAG
GA 
pBK-EGFP-
Tecta 
1-15 - complementary to the 5’ 
end of the Tecta signal peptide 
sequence 
16-32 - to the 3’ end of the 
EGFP coding sequence 
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EGFP-Tecta TCTTGTACAGC
TCGTCCATGCC
GAGAGTGAT  
pBK-EGFP-
Tecta 
1 is the 3’ end of the Tecta ORF 
2-31 - the 5’ end of the EGFP 
coding sequence 
TectamCherry
t2EGFP-F 
ACGAGCTGTA
CAAGATGTAT
CCATTTTGGCA
GAA 
pBK-EGFP-
Tecta 
1-14 - complementary to the 5’ 
end of the EGFP coding 
sequence 
15-34 - to the 3’ end of the 
Tecta ORF 
TectamCherry
2EGFP-R 
GAGCTCCCTG
GGCTGAGCTT
GGTGCCGAA 
pBK-EGFP-
Tecta 
Complementary to the 5’ end of 
the Tecta signal peptide 
sequence 
TectbC59G-
F1 
CTGGCACTCG
GGGGGCTGgGT
TACAACGGGG
TCCATGAAG 
pBK-EGFP-
Tectb C1837G 
Mutagenic primer, mutated 
nucleotide is specified by lower 
case 
TectbC59G-
R1 
CTTCATGGACC
CCGTTGTAACc
CAGCCCCCCG
AGTGCCAG 
pBK-EGFP-
Tectb C1837G 
Mutagenic primer, mutated 
nucleotide is specified by lower 
case 
TectbC61T-
F1 
GTACAAGCCC
CCCATCTgCCA
CTTCTACAGCC
AC 
pBK-EGFP-
Tectb Y1870C 
Mutagenic primer, mutated 
nucleotide is specified by lower 
case 
TectbC61T-
R1 
GTGGCTGTAG
AAGTGGcAGAT
pBK-EGFP-
Tectb Y1870C 
Mutagenic primer, mutated 
nucleotide is specified by lower 
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GGGGGGCTTG
TAC 
case 
pCAGlinker-F TCGATGCGGC
CGCTAGCGAA
TTCCCACCATG
GCTCGAGGAT
CC 
pCAG-
mCherry-Tecta 
Polylinker sequence 
pCAGlinker-
R 
GGCCGGATCC
TCGAGCCATG
GTGGGAATTC
GCTAGCGGCC
GCA 
pCAG-
mCherry-Tecta 
Polylinker sequence 
PBK-F1 GAACCGTCAG
ATCCGCTAGC 
pCAG-EGFP-
Tectb 
Complementary to CMV 
immediate early promoter 
Contains NheI restriction site 
(underlined)  
mmTectbSalI GGATCGTCGA
CacgcgtCTACAA
CACAGCCCAG
GTCC 
pCAG-EGFP-
Tectb 
Complementary to Tectb C-
terminal sequence 
Introduces SalI restriction site 
(underlined) and MluI 
restriction site (in lower case) 
Table 2.10. Primers used for making constructs described above. 
2.7.2. Cell culture procedures 
Cell culture procedures for the cell lines utilised in this study (MDCK and CaCo2) are 
described in section 2.2.1. Section 2.2.2. describes the lipofectamine 2000 transfection 
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method used in this chapter. The EGFP-Espin construct in which EGFP-Espin fusion is 
driven by CMV promoter was a kind gift from Prof. James R. Bartles (Northwestern 
University Feinberg School of Medicine, Chicago, USA) and was used to promote the 
formation of elongated microvilli on the apical surface of the cells transiently 
transfected with Tecta encoding constructs.  
2.7.2.1. Generating stable cell lines 
Two methods of generating stable cell lines were used in this research: cloning disks 
and the limiting dilution cloning technique. 
MDCK cell line stably expressing the pBK-Tecta-IRES-TurboFP635 construct was 
generated using cloning disks. MDCK cells were first transfected with 4 µg of pBK-
Tecta-IRES-TurboFP635 plasmid. After 48 hours the transfected cells were washed 
twice with phosphate buffered saline (PBS), trypsinised and resuspended in the MDCK 
media. Serial ten-fold dilutions of the cell suspension were then prepared and plated 
into 100 mm diameter culture dishes (Corning). G418, the antibiotic selective for the 
neomycin resistance gene, was added to the cell medium at a concentration of 0.5 
mg/ml. Cells were selected for 7 days until distinct isolated colonies were formed. 
Plates were then screened for fluorescent colonies using a Zeiss IM35 inverted 
microscope equipped with a rhodamine filter set and a 50 W mercury lamp. Selected 
colonies were marked with a black pen on the underside of the plate. The plates were 
then washed twice with PBS, and 3 mm diameter cloning disks (Sigma-Aldrich) soaked 
in trypsin/ethylenediaminetetraacetic acid (EDTA) were placed on top of the selected 
colonies. Cells were incubated with trypsin/EDTA for 10 min at 37
o
C. Each disk was 
then gently rubbed against the colony to pick up as many cells as possible and 
transferred into a 35 mm diameter polystyrene petri dish (Corning) containing growth 
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medium supplemented with geneticin (G418) at concentration 0.5 µg/ml. A duplicate 
dish for fixation and subsequent antibody staining was set up. When the culture reached 
70-80 % confluency, ten-fold serial dilutions were set up again. The cloning procedure 
was repeated at least four times to ensure that the final line originated from a single 
transfected cell. 
MDCK-based cell lines stably expressing either pCAG-mCherry-Tecta or pCAG-
EGFP-Tectb were generated using cloning by limiting dilution. MDCK cells were 
transfected with 4 µg of the appropriate vector. Following 48-hour incubation, the cells 
were washed twice with sterile PBS and treated with trypsin/EDTA. Cells were then 
triturated 10 times with a sterile glass Pasteur pipette, re-suspended in medium and 
counted. Cell density was adjusted to 10
5
 cells per ml with selection medium containing 
5 µg/ml of puromycin (Sigma-Aldrich). Cell dilutions containing 100 and 10 cells per 1 
ml of selection medium were prepared. Aliquots (100 µl) of high concentration cell 
suspension (100 cells per ml) were dispensed into 48 wells of a 96-well plate (Nunc). 
Aliquots (100 µl) of the 10 cell/ml cell suspension were dispensed into the remaining 48 
wells. The plates were incubated for 14 days, changing the selection medium after the 
first seven days. They were then checked for the presence of isolated colonies on a Zeiss 
Cell Observer Axiovert 200M. mCherry and EGFP fluorescence were detected on the 
same microscope using rhodamine and fluorescein isothiocyanate (FITC) filters 
respectively. Clones that appeared to be derived from a single cell and expressing the 
appropriate fluorescent protein were selected. Cells were washed, trypsinised and 
transferred to 35 mm diameter petri dishes with selection medium. Cloning was 
repeated three more times. 
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2.7.2.2. Mitomycin C treatment of MDCK stable cell lines 
MDCK cells stably transfected with pBK-Tecta-IRES-turboFP635 construct were 
dispensed in two 35 mm diameter petri dishes containing sterile glass coverslips and 
medium. G418 was not added to the medium to enhance the protein expression. The 
medium of one dish was supplemented with 10 µg/ml of mitomycin C (Sigma). Both 
dishes were incubated at 37
o
C for 2 hours. The medium from both dishes was then 
aspirated and they were washed 3 times with PBS. Cells were then fed with a standard 
culture medium and incubated for 8 days at 37
o
C. The coverslips with cells were then 
washed three times in PBS and fixed (2.4.1). They were then pre-blocked with Triton 
X-100 and stained with antibodies (Table 2.11) (2.4.3). Cells were then examined by 
wide-field fluorescence microscopy (Zeiss Axioplan 2). 
2.7.2.3. Cell cultivation on different substrates 
MDCK cells stably transfected with pBK-Tecta-IRES-turboFP635 were grown on 
sterile glass coverslips covered with special substrates which allow cell adhesion and 
spreading: BD Matrigel
TM 
(BD Biosciences), laminin (Sigma-Aldrich), poly-D-lysine 
(PDL) (Sigma-Aldrich) and ammonium polymerised collagen. 
Glass coverslips were placed into 35 mm diameter petri dishes using sterile forceps and 
coated with individual substrates. 
 BD Matrigel
TM 
was thawed overnight at 4
o
C and mixed with a pre-chilled pipette to 
ensure homogeneity. It was then diluted with cold culture medium without FBS to a 
concentration of 3 mg/ml. The diluted BD Matrigel
TM 
was added to glass coverslips so 
that it covered the entire cell growth surface. Dishes were incubated at room 
temperature for 1 hour while the BD Matrigel
TM
 polymerised onto the coverslip. 
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Afterwards, the medium was removed by aspiration, the dishes were rinsed with sterile 
PBS and used for culturing cells.  
Laminin was diluted with HBSS (GibCo) to a concentration of 5 µg/ml and added onto 
the coverslips to cover the cell growth area. The dishes were incubated for 2 hours at 
37
o
C. The coating solution was then removed by aspiration and dishes were carefully 
washed with PBS.  
Poly-D-lysine (PDL) working solution had a concentration 20 µg/ml and was prepared 
with sterile H2O. Before culturing cells, dishes were incubated with PDL solution at 
room temperature overnight and rinsed with PBS.  
Collagen substrate was prepared by spreading a drop of rat tail collagen (BD 
Biosciences) onto a glass coverslip with the back of the hook of a bent sterile glass 
Pasteur pipette in order to cover the entire surface of the coverslip with a thin layer of 
collagen. In a fume hood, 2 ml of 25 % ammonia solution (Fisher Chemical) was mixed 
with 1 ml of sterile H2O and soaked into a piece of filter paper. It was then placed in a 
140 mm petri dish (Sterilin) together with the petri dishes containing coverslips. The 
lids of the 35 mm diameter petri dishes were shifted to expose the coverslips. The 
ammonium polymerisation lasted for 25 min. Afterwards the petri dishes with the 
coverslips were covered with the lids again, transferred to the cell culture hood and left 
there for additional 15 min. The coverslips were then washed twice with sterile H2O and 
used for culturing cells.  
After a week of growing on coated coverslips and on one uncoated control coverslip, 
cells were fixed, preblocked with 0.1 % of Triton X-100 to permeabilise cell 
membranes and stained with antibodies (Table 2.11). The cells were then examined by 
wide-field immunofluorescence and confocal microscopy.  
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2.7.2.4. Generating cell spheres 
To prepare the collagen - BD Matrigel
TM
 master mix (CMM) the following compounds 
were mixed on ice in the order given: 700 µl acid-soluble rat tail collagen (BD 
Biosciences), 1700 µl sterile H2O, 400 µl 10x minimum essential medium (MEM) 
(Sigma-Aldrich), 80 µl 1M hydroxyethyl-piperazine ethanesulafonic acid (HEPES) 
(Sigma), 36 µl 3 M NaOH, 360 µl fetal bovine serum (FBS) “Gold” (PAA), 40 µl 200 
mM L-glutamine, 120 µl of a 11% NaHCO3 solution and 640 µl BD Matrigel
TM
 (BD 
Biosciences) (Sourisseau et al., 2006). 200 µl of CMM were placed on sterile glass 
coverslips in 35 mm petri dishes and allowed to set for 1 hour at 37
o
C. MDCK cells 
stably transfected with pCAG-mCherry-Tecta plasmid were washed twice with sterile 
PBS, treated with trypsin/EDTA, re-suspended in standard culture medium and counted. 
Cell concentration was adjusted with culture medium and the suspension was dispensed 
into 15 ml tubes, 10
5
 cells per tube. The tubes were then centrifuged at 300g for 5 min 
(accuSpin
TM
 400 centrifuge, Fisher Scientific). The supernatant was aspirated, 200 µl of 
CMM was added to each tube and mixed with the cell pellet. The mixture was added on 
the top of the CMM layer on the coverslip, using the contents of one tube for each 
coverslip. Coverslips were incubated for 1 hour at 37
o 
C and then 3 ml of MDCK 
medium was carefully added to each dish. The cells were grown for 1 week and 2 weeks 
at 37
o
C, they were then fixed, cryosectioned (2.4) and stained. 
2.7.4. Gene-gun transfection of cochlear cultures 
2.7.4.1. Mouse cochlear culture preparation 
Mouse cochlear cultures were prepared by using a technique previously described 
(Russell and Richardson, 1987). P2 CD1 and Tecta
ΔENT/ΔENT
/Tectb null mouse pups were 
killed by cervical dislocation. After the cartilaginous capsule was removed, cochleae 
were dissected in HEPES buffered (10 mM, pH 7.2) Hank’s balanced salt solution 
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(HBSS). The stria vascularis and the modiolar tissue were removed and the cochlear 
coils were divided into apical and basal parts. The apical and basal coils were then 
explanted onto a rat tail collagen coated glass coverslip and fed with a drop of medium 
containing 93 % Dulbecco’s modified Eagle’s medium (DMEM) F-12 Ham nutrient 
mixture (Sigma) and 7 % FBS “Gold” (GE Healthcare, PAA) with 10 µg/ml ampicillin. 
Explanted cultures were sealed into Maximow slide assemblies with a mixture of wax 
and vaseline and grown for 24 hours at 37
o
C.  
2.7.4.2. Gene-gun gold bullets preparation 
25 mg of 1 µm gold particles (Bio-Rad) were used to prepare each set of bullets. 10 mg 
of polyvinylpyrrolidone (PVP) (Bio-Rad) were diluted in 500 µl of fresh dry 100 % 
ethanol. 35 µl of this solution were added to 7 ml of fresh 100 % ethanol (Fisher 
Scientific) to obtain a PVP solution of final concentration 0.02 mg/ml. A stock solution 
of 0.5 M spermidine trihydrochloride was prepared as follows: 31.75 mg of spermidine 
trihydrochloride (Sigma) were added to 250 µl of sterile H2O. The stock solution was 
then diluted ten-fold to prepare a 0.05 M working solution. 
Spermidine trihydrochloride (50 µl of the 0.05 M working solution) was added to 25 mg 
of gold particles. The resulting gold suspension was vortexed (Spinmix) for 10 sec, 
sonicated for 10 sec in a Decon sonic bath (Ultrasonics Ltd.), then vortexed for 10 sec 
again and sonicated again for 10 sec. Plasmid DNA (50 µg) was added, and the mixture 
was vortexed for 5 sec. An equal volume of 1 M CaCl2 was added to the mixture drop 
by drop, vortexing for 5 sec after the addition of each drop. The suspension was allowed 
to stand for 10 min at room temperature and then centrifuged for 15 sec in a bench 
centrifuge (accuSpin Micro, Fisher Scientific). The supernatant was discarded and the 
pellet was washed 3 times with 100% ethanol. The pellet was then re-suspended in 200 
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µl of 0.02 mg/ml PVP in ethanol, carefully mixed by pipetting up and down, and 
transferred to a microcentrifuge tube with the remaining 6.8 ml of 0.02 mg/ml PVP. The 
suspension was gently shaken for about 10 min to prevent gold particles from clumping. 
Bullets were made using Tefzel tubing with an external diameter of 3.175 mm and 
internal diameter of 2.36 mm (Bio-Rad). The tubing was pulled through the tubing 
holder of the Tubing Prep Station and dried with nitrogen for 10 min. Afterwards the 
gold-DNA suspension was loaded into the tubing with a syringe and allowed to settle 
for 5 min. The PVP solution was then slowly aspirated by the syringe. The tubing 
holder was first rotated through 180
o
, allowed to stand for 4 sec  to spread the gold and 
then rotated continuously for 30 sec to allow the gold to spread evenly on the inside 
surface of the tube. Nitrogen gas was flushed through the rotating tubing for 5 min at 
0.35 l/min to dry the gold particles attached to the wall. After the coated tubing was 
removed from the holder the sparsely and unevenly coated ends were trimmed with a 
razor blade. The remaining part of the tube was cut on a Tubing Cutter (Bio-Rad) into 
individual cartridges of 1.27 cm length. Cartridges were stored at 4
o
C in labelled 15 ml 
tubes with a bed of silica gel particles (BDH) isolated with foil. 
2.7.4.3. Gene gun transfection 
Cochlear cultures were transfected with the required plasmid DNA using a Helios
TM
 
gene gun. The gene gun was connected to a helium gas tank and the pressure was set at 
110 psi. An empty cartridge holder was inserted into the gun, and the gun was 
discharged 3 times to pressurise the system. Bullets were then loaded into the cartridge, 
and the cartridge was placed back in the gun. Cochlear cultures were taken out from the 
Maximow slide assembly, excess culture medium was aspirated with a piece of sterile 
filter paper. The coverslip with the culture attached was placed at the centre of the 
pedestal, covered with a fresh 3 µm cell culture insert (Becton Dickinson Labware) and 
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positioned directly under the gene gun. The gene gun was discharged once with a single 
bullet. The coverslip was immediately placed into the 35 mm petri dish and examined 
under the dissection microscope (Zeiss Stemi 2000). The “shot” was repeated if no gold 
was detected on the explants. 2 ml of Rat Cochlear culture Medium (RCM) (93 % of 
DMEM F-12, 7 % of FBS, 0.1 % of 10 µg/ml ampicillin) were added to the dish and the 
culture was incubated at 37
o
C in a CO2 incubator for 24 or 48 hours to allow gene 
expression. 
2.7.5. Correlative light-electron microscopy 
Wild type mouse cochlear cultures at P2+1 days in vitro (DIV) were gene gun 
transfected with pBK-EGFP-Tectb DNA, incubated for 24 hours at 37
o
C, fixed and 
stained with goat anti-GFP (FITC) antibody (Abcam) at a dilution of 1:2000. Stained 
cultures were placed in a chamber with PBS and photographed using a SPOT camera 
mounted on a Zeiss Axioplan 2 microscope. Using wide-field fluorescence images, a 
montage was created in Adobe Photoshop 7.0 where cells of interest were marked. 
Cultures were then incubated with R7 primary antibody to Tectb and double-labelled 
with 10 nm gold-conjugated donkey anti-rabbit antibody (BBInternational) as described 
in section 5 of Appendix. They were then processed for either scanning electron 
microscopy (SEM) or transmission electron microscopy (TEM) (2.5). Montage maps 
obtained with light microscopy were used to identify and image cells of interest in the 
electron microscopy. 
2.7.6. Western blotting 
Cell and medium samples were collected as described in section 2.3.1 of. SDS-PAGE 
gel and blotting procedures were carried out as previously described (2.3.2 and 2.3.3). 
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For samples expressing Tecta a 7.5 % resolving gel was used; a 10 % resolving gel was 
prepared for samples expressing Tectb (2.3.2).  
To detect Tecta protein in a medium or cell lysates R9 rabbit antiserum to chick α1-
tectorin subunit (Knipper et al., 2001) was used at a dilution of 1:1000. mCherry protein 
was detected with a rat monoclonal antibody to monomeric red fluorescent proteins 
(ChromoTek) at a dilution of 1:1000. R7, rabbit antiserum to chick Tectb (Knipper et al., 
2001) at a dilution of 1:1000 was used for Tectb protein detection. For EGFP protein 
anti-GFP rabbit serum (Invitrogen, Molecular probes), 1:1000, was used. Anti-rat 
alkaline phosphatase (AP)-conjugated IgG, generated in goat (DAKO), 1:1000, was 
utilised to detect anti red primary antibody. For other primaries, goat anti-rabbit AP-
conjugated IgG (DAKO) was used at a dilution of 1:1000.  
2.7.7. Immunolabelling and microscopy 
The detailed procedures of sample preparation for immunofluorescence microscopy and 
TEM/SEM are described in sections 2.4 and 2.5. The list of antibodies used for 
immunofluorescence microscopy is shown in Table 2.11, for SEM/TEM - in Table 2.12. 
When phalloidin staining was used, the cells and cochlear cultures were first 
permeabilised with Triton X-100 (2.4.3). 
Protein Primary 
antibody 
Primary 
antibody 
dilution 
Secondary antibody 
(Molecular Probes, 
Invitrogen) 
Secondary 
antibody 
dilution 
Tecta Anti-Tecta (R9) 1:1000 Alexa Fluor 488 goat 
anti-rabbit or 555 donkey 
anti-rabbit 
1:500 
Tectb Anti-Tectb (R7) 1:1000 Alexa Fluor 488 goat 1:500 
86 
 
anti-rabbit or 555 donkey 
anti-rabbit 
EGFP Goat anti-GFP 
(FITC) (Abcam) 
1:2000 Alexa Fluor 488 donkey 
anti-goat IgG 
1:500 
Stereocilin Rabbit anti-
stereocilin 
antibody 
1:1000 Alexa Fluor 488 goat 
anti-rabbit 
1:500 
Table 2.11. Primary and secondary antibodies used for immunofluorescence microscopy 
 
Protein Primary 
antibody 
Primary 
antibody 
dilution 
Gold-conjugates  Gold-
conjugate 
dilution 
Tecta Anti-Tecta (R9) 1:1000 10 nm gold-conjugated donkey 
anti-rabbit (BBInternational) 
Or 25 nm gold-conjugated 
donkey anti-rabbit IgG (Abcam) 
1:10 
Tectb Anti-Tectb (R7) 1:1000 10 nm gold-conjugated donkey 
anti-rabbit (BBInternational) 
 
1:10 
Table 2.12. Primary antibodies and gold-conjugates used for TEM/SEM. 
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2.8. Materials and methods used for generating and studying 
Ceacam16 null mutant mouse 
2.8.1. Making the Ceacam16 null mutant mouse 
JM8A1.N3 embryonic stem (ES) cells (C57BL/6N background) with confirmed 
targeting of the Ceacam16 gene were obtained from the Knockout Mouse Consortium 
(IKMC Project ID: 69148; UC Davis, California, USA), indirectly through the 
Wellcome Trust Sanger Institute (Cambridge, UK). The vector used for targeting 
Ceacam16 in ES cells is shown in Fig.2.8. 
 
Figure 2.8. Construct used for ES cell targeting. Homology arms of 6299 bp (5’) and 4005 bp (3’) 
flank an L1L2 targeting cassette. Yellow rectangles in the 5’ and 3’ homology arms represent exons 
1 and 6 respectively of Ceacam16. En2SA stands for En2 splice acceptor, IRES - internal ribosome 
entry site, βgal - β-galactosidase gene, pA - SV40 polyadenylation site. The neomycin resistance 
gene (neo) is driven by a human β-actin promoter. LoxP - lox P sites for cutting by Cre-recombinase, 
FRT-sites - flippase recognition target sites for interaction with the flippase recombination enzyme. 
The targeting cassette is inserted into R3R4_pBR_DTA+_Bsd_amp plasmid backbone which 
includes: a DTA (diptheria toxin A) negative selection cassette, a phosphoglycerate kinase 1 
promoter (PGK), a blasticidin resistance sequence (BsdR), an ampicillin resistance sequence (AmpR) 
and a site for AsiSI restriction enzyme. Ori is an origin of replication site. The picture was obtained 
from the Wellcome Trust Sanger Institute webpage. 
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The Ceacam16 gene in the ES cell line contains a targeted replacement of exons 2 to 5 
with a bacterial lacZ ORF. The LacZ reporter encodes β-galactosidase that can catalyse 
the hydrolysis of X-Gal, producing a blue stain in cells in which Ceacam16 is expressed. 
Therefore, in the cochlea of the Ceacam16 null mutant mouse model a blue staining will 
appear in the cells that would normally express the Ceacam16 gene. 
I microinjected targeted ES cells into the blastocysts from the albino C57BL/6J-Tyr
c-2J
 
mice (Charles Rivers, UK). Microinjected blastocysts were surgically transferred into 
F1 pseudopregnant females. If the coat of a mouse pup obtained from the injections 
consisted of black and white patches, I identified the animal as chimeric (Fig.2.9). Non-
chimeric newborns were albino. Chimeric male mice were then mated to C57BL/6J-
Tyr
c-2J
 animals of albino background. Patched offspring confirmed germ line 
transmission. 
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Figure 2.9. A chimeric mouse pup is identified by a coat which is a mix of black and white patches. 
Note the left eye is black and therefore of C57B1/6N origin and the right eye is red and of 
C57BL/6J-Tyr
c-2J
 albino origin.  
2.8.2. Genotyping mice 
For genotyping Ceacam16 targeted mice, genomic DNA was isolated from tail snips 
(Legan et al., 2000). To minimise the number of steps in the genotyping protocol, DNA 
was not purified and its concentration was not measured. The PCR reaction mixture was 
set up as follows: 
Reagents Amount used 
10x PCR reaction buffer with 20 mM 
MgCl2 
2.5 µl 
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10 mM dNTPs 0.5 µl 
25 pmol forward primer  0.5 µl 
25 pmol reverse primer  0.5 µl 
Uracil-DNA Glycosylase (Roche) 0.4 units 
Extracted DNA  2 µl 
FastStart Taq DNA polymerase (Roche)  0.5 units 
Sterile H2O 18.65 µl 
Table 2.13. Genotyping PCR mixture. 
The following primers were used: 
Primer Sequence Location 
CeagenF1 5’GGGGCATACCTAGCAAGA
GTAAGG3’ 
located at the 3’ end of exon5 
Lar3.1 5’GTGTTGCCCAAGAAGACA
ATCAGG3’ 
anneals to the 5’ end of the en2-
intron 
CeagenF2 5’CAAGGACCTGCTAGTCTAT
GCCTG3’ 
complementary to the middle of 
exon5 
CeagenR2 5’AGGGTAGGGTGTGACGAG
TGAGTG3’ 
located at the 5’ end of intron 5 
Table 2.14. Primers used for genotyping PCR. 
Reactions were cycled as listed: 
6. initial denaturation at 94oC for 2 min 
7. denaturation at 94oC for 15 sec 
8. annealing at 60oC for 20 sec 
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9. extension at 72oC for 30 sec 
10. final extension at 72oC for 5 min 
Steps 2 to 4 were repeated 40 times. PCR products were analysed by gel electrophoresis 
(Appendix 1.4). For wild type mice a product of 265 bp was amplified with CeagenF2 
and CeagenR2 primers. Primers CeagenF1 and Lar3.1 amplified a 308 bp fragment in 
mutant mice. Both products were detected in heterozygous animals. 
2.8.3. Transient expression of Ceacam16 and Tectb in HEK 293 cells 
HEK 293 cells were cultured as described in 2.2.1, and transiently transfected with 
plasmid constructs according to 2.2.2. Two plasmids were used, pcDNA6-Ceacam16-
V5His (a kind gift from Dr. Jing Zheng, Northwestern University, Chicago, USA) 
expressing Ceacam16 C-terminally tagged with V5 and 6His tags (Fig.2.10) and pBK-
EGFP-Tectb, expressing N-terminally EGFP tagged Tectb (Fig.2.5, b). 
HEK 293 cells were transfected with individual plasmids and also co-transfected with 
both plasmids. Sham transfected controls were used. All transfections were performed 
in duplicate. 24 hours after transfection cells were fed with a serum-free medium. 48 
hours later the medium was collected and used for western blotting. 
2.8.4. Co-immunoprecipitation of Tetctb and Ceacam16 proteins from culture 
medium and western blotting 
Serum free cell culture medium was collected as described in Appendix 3.1 and then 
centrifuged at 50,000 rpm for 15 min at 4
o
C using a Beckman TL-100 Ultracentrifuge to 
pellet cell debris. One set of culture media from Sham, Tectb, Ceacam16 and 
Tecb+Ceacam16 transfections was incubated with 0.6 mg/ml rabbit anti-Tectb IgG 
pooled serum. The antibody was prepared by Dr. Kevin Legan to the amino acid 
sequence HPSFPPKKKLPSFWKR from the ZP domain of Tectb. 
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Figure 2.10. Schematic representation of pcDNA6/V5HisB plasmid. pCMV - human 
cytomegalovirus immediate early promoter, BGH pA - bovine growth hormone polyadenylation 
sequence, f1 ori - origin of replication site, SV40 ori - SV40 promoter and origin, EM7 - bacterial 
EM7 promoter, Blasticidin - blasticidin resistance gene ORF, SV40 pA - SV40 polyadenylation 
sequence, pUC ori - pUC origin of replication, Ampicillin - ampicillin resistance gene ORF. T7 
promoter sequence is followed by a polylinker, which contains V5 epitope connected to 6xHis tag 
through an AgeI restriction site. Term stands for a termination codon sequence (map is modified 
from an Invitrogen data sheet). 
Culture media from the second set of Sham, Tectb, Ceacam16 and Tecb+Ceacam16 
transfectants was incubated with rabbit polyclonal anti-V5 antiserum (Sigma, V8137) at 
a dilution of 1:2000. This process of pulling protein complexes from the culture 
medium is further referred as a pull down. 
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Tubes were incubated at 4
o
C for 24 hours on the rotator. Meanwhile, 25 mg of protein 
A-Agarose (Sigma-Aldrich) were re-suspended in 1 ml of PBS. The mixture was 
centrifuged at 13,000 rpm for 1 min at room temperature using a benchtop centrifuge 
(accuSpin Micro, Fisher Scientific). The supernatant was discarded and the pellet of a 
swollen protein A-agarose was washed twice more with PBS. Afterwards, 40 µl of the 
1:1 protein A-agarose suspension in PBS were added into each immunoprecipitation 
mixture. Tubes were then rotated for an additional 2 hours at 4
o
C. The protein A-
agarose was then pelleted by brief centrifugation at 13,000 rpm at room temperature and 
then washed three times with PBS. The pellets were mixed with 30 µl of 1x RSB, boiled 
at 104
o
C for 4 min, mixed by pipetting, centrifuged for 1 min at 13,000 rpm and then 
electrophoresed through a 10 % SDS-PAGE gel (2.3.2). Western blotting and protein 
visualization were performed as in 2.3.3. Duplicate western blots were set up for each 
immunoprecipitation reaction. Antibodies used for probing the polyvinylidene 
difluoride (PVDF) membrane are summarised in Table 2.15. All primary and secondary 
antibodies were used at a dilution of 1:1000. 
Antibodies used for pulling down 
proteins from the culture medium 
Antibodies used for probing PVDF 
membrane 
Primary antibody Secondary antibody 
Rabbit anti-Tectb IgG pooled serum Rabbit anti-Tectb 
IgG pooled serum 
Goat anti-rabbit 
AP-conjugated IgG 
(DAKO) 
Monoclonal anti-
V5 antibody 
(Invitrogen) 
Goat anti-mouse 
AP-conjugated IgG 
(DAKO) 
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Rabbit polyclonal anti-V5 antiserum Rabbit anti-Tectb 
IgG pooled serum 
Goat anti-rabbit 
AP-conjugated IgG 
(DAKO) 
Monoclonal anti-
V5 antibody 
(Invitrogen) 
Goat anti-mouse 
AP-conjugated IgG 
(DAKO) 
Table 2.15. Antibodies used for protein immunoprecipitation and for western blotting. 
2.8.5. Western blotting of tectorial membranes lysates 
The TMs were dissected from cochleae into HEPES-buffered (10 mM, pH 7.2) HBSS. 
The TM lysates were prepared according to the procedure described in Legan et al., 
2000. A modified step-gradient gel was used to perform SDS-PAGE electrophoresis. 4 
µl of each sample (approximately two tectorial membranes) were loaded onto the 4 % 
stacking gel and resolved on a complex resolving gel consisting of the 8.25 % resolving 
gel on top and the 12 % resolving gel underneath. Proteins were transferred onto 
Hybond-P membrane using a wet transfer protocol. For the wet transfer, gel pad, 
membrane, filter papers and transfer foams were equilibrated with transfer buffer (25 
mM Tris, 192 mM glycine, 10 % methanol). The transfer sandwich was assembled as 
follows: negative electrode, the transfer foam, three sheets of Whatman 3 MM paper, 
the gel, the PVDF membrane, three pieces of Whatman 3 MM paper, the transfer foam 
and the positive electrode. The sandwich was clamped vertically and placed in the tank 
with a transfer buffer. The transfer was performed overnight at 30 V (constant voltage) 
keeping the buffer temperature at 4
o
C. The membranes were probed with rabbit purified 
IgG to the CGRLEIHRNKNSTTVESK amino acid sequence of Tecta at a dilution of 
1:1000, rabbit purified IgG to the CYNKNPLDDFLRPDGR amino acid sequence of 
Tectb at a dilution of 1:1400 (both antibodies generated by Dr. Kevin Legan) and rabbit 
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anti collagen type IX antibody at a dilution of 1:1500. Anti-Ceacam16 staining was 
performed with anti Ceacam16 antibody (kindly provided by Dr. Jing Zheng, 
Northwestern University, Chicago, USA) which was generated to 
SLLVQKLNLTDAGRYTLKTVT amino acid sequence of IgV-like N2 domain of 
Ceacam16 (Fig.2.11) and used at a dilution of 1:20000. The secondary antibody used 
for all four primary antibodies was horseradish peroxidase (HRP)-linked anti-rabbit IgG 
(True-blot, eBioscience) at a dilution of 1:1000. The band densitometry analysis was 
performed using Image J software. The amount of Tecta and Tectb in the TMs of 
Ceacam16
βgal/βgal
 mice was expressed as a percentage of that seen for Tecta and Tectb in 
Ceacam16
+/βgal
 mice. Collagen type IX was used to normalise the amount of protein 
present when quantifying the density of the Tecta and the Tectb bands. 
 
Figure 2.11. Amino acid sequence of Ceacam16. Yellow colour marks IgV-like domains, green 
indicates IgC-like domains. Seven predicted N-glycosylation sites are shown in red. The arrow 
marks the proteolytic cleavage site downstream from the signal peptide, a characteristic of secreted 
or transmembrane proteins, asterisks indicate cysteine residues. The peptide sequence used to 
generate the anti-Ceacam16 antibody is underlined. From Zheng et al., 2011.  
2.8.6. Light and transmission electron microscopy 
Animals were killed by cervical dislocation. Cochleae were rapidly removed and placed 
in PBS for dissection, the oval and round windows were opened, and the apex of each 
cochlea was punctured. For TEM about 50 µl of fixative (2.5) was perfused through the 
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openings, and the cochleae were fixed in the same fixative for additional 2 hours. After 
the fixation, cochleae from animals older than 3 weeks were decalcified with 0.5 M 
EDTA (pH 8.2) for 7 days at 4
o
C. Cochleae were then postfixed in 1 % OsO4 (detailed 
description in 2.5). The cochleae were then dehydrated, equilibrated with propylene 
oxide and imbedded in Epon as described in section 2.5. For light microscopy, 1 µm 
sections were stained with toluidine blue and then photographed with a SPOT camera 
mounted on a Zeiss Axioplan 2 microscope. Ultrathin sections for TEM were prepared 
according to section 2.5. 
2.8.7. Immunofluorescence microscopy and X-Gal staining detection 
Cochleae were dissected as in 2.8.6 and used either for staining with X-Gal (2.6) or 
cryosectioned (2.4.2) for immunostaining (2.4.3). Whole mounts of cochleae stained 
with X-Gal were photographed under a Leica MZ10F microscope using a ProgRes C3 
camera and then re-fixed, cryosectioned and imaged using Zeiss Axioplan 2 microscope.  
Cryosections of the cochleae for immunostaining were preblocked with 10 % HS in 
PBS and then stained with primary antibodies (Table 2.16) overnight in a humid 
chamber. Afterwards, the slides were washed 3 times in PBS, stained with a secondary 
antibody, washed again and mounted as described in 2.4.3. Sections were analysed 
using a fluorescence Zeiss Axioplan 2 microscope. 
Protein Primary 
antibody 
Primary 
antibody 
dilution 
Secondary 
antibody 
Secondary 
antibody 
dilution 
β-galactosidase anti-β-
galactosidase 
(anti-βgal) 
1:200 Alexa Fluor 
488 goat anti-
rabbit 
1:500 
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(Promega) 
Ceacam16 anti-Ceacam16 
(CC16) 
1:1000 Alexa Fluor 
488 goat anti-
rabbit  
1:500 
Otoancorin anti-otoancorin 
(OA) 
1:1000 Alexa Fluor 
488 goat anti-
rabbit  
1:500 
Tecta anti-Tecta (R9) 1:1000 Alexa Fluor 
488 goat anti-
rabbit  
1:500 
Tectb anti-Tectb (R7) 1:1000 Alexa Fluor 
488 goat anti-
rabbit  
1:500 
Collagen IX anti-collagen 
IX (M2) 
1:1000 Alexa Fluor 
488 goat anti-
rabbit  
1:500 
Otogelin anti-otogelin 
(OG) 
1:1000 Alexa Fluor 
488 goat anti-
rabbit  
1:500 
Table 2.16. Antibodies against proteins expressed in the organ of Corti of Ceacam16 null mutant 
mice and the dilutions at which they were used.  
For lectin staining sections were preblocked with 3 % bovine serum albumin (BSA) 
(Sigma-Aldrich) in PBS for an hour and then stained with FITC-conjugated soybean 
agglutinin (SBA) (Vector labs) at a dilution of 1:1000. Staining was performed 
overnight in a humid chamber.  
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Texas Red phalloidin or fluorescein phalloidin were used as counter-stains at a dilution 
of 1:500. 
2.8.8. Cochlear microdissection 
When sectioning fixed cochleae for immunofluorescence/toluidine blue staining, the 
blade goes through the organ of Corti as shown in Fig.2.12. Therefore four turns of the 
organ of Corti named apical 1, apical 2, basal 1 and basal 2 are observed in the cross-
section through the cochlea (refer to Fig.2.12).Unless stated otherwise, apical 2 and 
basal 2 turns are described in the results section. 
 
Figure 2.12. Sectioning of the mouse cochlea. Panel a - fixed cochlea whole mount from a 
Ceacam16 null mutant mouse showing the spiral of the organ of Corti stained with X-Gal. B and c 
are schematic representations of the organ of Corti in back/front (b) and up/down (c) views. The red 
rectangle in b and red line in c represent the sectioning blade. As a result, four cochlear turns are 
observed in the cross-section: apical 1 (A1), apical 2 (A2), basal 1 (B1) and basal 2 (B2). 
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CHAPTER 3 
Development of an in vitro model system for 
studying the processing, secretion and assembly 
of tectorial membrane proteins 
3.1. Introduction 
Alpha-tectorin (Tecta) and beta-tectorin (Tectb) are glycoproteins that are found 
exclusively in the inner ear. Through interaction with each other and with other proteins 
they form the secreted matrix of the otoconial and tectorial membranes. In the tectorial 
membrane (TM), Tecta and Tectb form the striated-sheet matrix which surrounds the 
radially orientated collagen fibrils (Hasko and Richardson, 1988). The structure of both 
tectorins suggests that they can form hetero- or homopolymers. It is, however, unclear 
how these proteins are secreted, processed and assembled into the matrices observed, 
and how deafness-causing mutations in Tecta influence these processes.  
As the epithelial cells of the inner ear that produce the tectorins in vivo are extremely 
difficult to access and isolate, the aim of this project was to create an in vitro cell 
transfection model which could help to examine some of these processes (Zheng at al, 
2010). Unpublished observations from the host laboratory indicated that non-polarised 
cell lines, such as human embryonic kidney 293 cells (HEK293), failed to secrete 
tectorins on their surfaces. Thus I transiently transfected polarised Madin-Darby canine 
kidney (MDCK) and colorectal adenocarcinoma 2 (CaCo2) cell lines of epithelial origin 
with fluorescently-tagged tectorin constructs to determine whether these proteins can be 
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expressed in vitro. Microvilli which are similar in structure to hair cell stereocilia were 
elongated by transient over-expression of fluorescently-tagged espin (Zheng et al., 
2010). MDCK derived cell lines stably expressing tectorin constructs were utilised to 
study processing and secretion of the tectorins. Stable cells grown in a mixture of 
collagen and Matrigel
TM
 formed polarised epithelial spheres expressing tectorin 
filaments in the lumen (Witteveen, 2008). To circumvent some disadvantages of cell 
monolayer and sphere models, I used gene gun transfection to transfect the recombinant 
tectorin constructs into various cell types in neonatal mouse cochlear cultures. 
Mutations in the ZP domain of Tecta that are known to cause human hereditary hearing 
loss I introduced by site directed mutagenesis into the ZP domain of Tectb encoding 
plasmid, and studied their effect on matrix formation. 
3.2. Results 
3.2.1. The MDCK cell monolayer system as an in vitro model for studying tectorin 
secretion and assembly 
3.2.1.1. Choosing an appropriate cell line 
As hair and supporting cells of the organ of Corti are epithelial cells, it is possible that 
certain characteristics of epithelial cells, e.g. apical-basal polarity, specialised cell to 
cell contacts and free apical surface, might be essential for expressing tectorial 
membrane proteins. Thus, the choice fell on established fast-growing epithelial cell 
culture models, MDCK and CaCo2 cells. Both cell types were transiently transfected 
with pBK-Tecta-IRES-turboFP635 plasmid to induce Tecta expression. The transfection 
experiment was repeated at least three times to ensure that the obtained results are 
reliable. Due to the presence of the IRES, turboFP635 was expressed as a separate 
protein. Cells were co-transfected with Espin-EGFP encoding construct to elongate the 
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apical microvilli which are related to hair cell stereocilia. Both transfected cell lines 
expressed Tecta protein (Fig.3.1, a, a’) and displayed enhanced microvilli growth 
(Fig.3.1, b, b’). Confocal microscopy indicated that MDCK cells secreted Tecta on their 
apical surface where it aggregated among the microvilli (Fig.3.2, a, c). CaCo2 cells, in 
contrast, did not show any signs of extracellular Tecta expression and accumulated the 
protein in the cytoplasm (Fig.3.2, d, f). Based on these observations, MDCK cells were 
selected for further in vitro work. 
3.2.1.2. pBK-Tecta-IRES-turboFP635 stably transfected cells 
To study how tectorins form extracellular matrix and how deafness causing mutations in 
Tecta can disrupt this process, high levels of protein expression are required. Having a 
cell monolayer where every cell expresses tectorins on its apical surface would greatly 
facilitate TEM and SEM investigations. To achieve a long-term high-rate of expression 
of tectorins by MDCK cells, a stable transfection protocol was utilised. G418 positive 
selection of MDCK cells stably transfected with the pBK-Tecta-IRES-turboFP635 
construct revealed that the red fluorescence of turboFP635 protein, with an excitation 
wavelength of 588 nm (similar to that of Texas Red phalloidin), was not detected with 
the rhodamine filter during the live fluorescence microscopy screening. Thus, the 
screening was performed on fixed duplicate dishes stained with anti-Tecta antibody. 
After the cloning was repeated twice (the procedure is detailly explained in 2.7.2.1), two 
cell lines expressing Tecta were selected from derived neomycin-resistant colonies of a 
number greater than 15: line 7 (Fig.3.3, a - c) and line 11 (Fig.3.3, a’ - c’). The majority 
of cells in both cell lines seemed not to express Tecta on their apical surface, although a 
few of the line 7 cells might have secreted Tecta extracellularly (Fig.3.3, a and c).  
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Confocal microscopy of cell line 7 indicated that Tecta-positive cells secrete amorphous 
Tecta aggregates on their cell apical surface (Fig.3.4, a’ and c’). Tecta expression in line 
11 cells was seen throughout the cytoplasm in a non-polarised manner with no signs of 
secretion on the cell surface (Fig.3.5, a’ and c’). Based on the presence of extracellular 
Tecta expression, line 7 was chosen for further work. 
3.2.1.3. Mitomycin C treatment of Tecta expressing cells 
It is possible that to effectively secrete Tecta on the apical surface, MDCK cells first 
need to accumulate enough protein inside. The process of protein accumulation would 
be disrupted by mitosis. Mitomycin C was used to prevent cell division in the pBK-
Tecta-IRES-turboFP635 stable cell line. Wide-field fluorescence microscopy showed 
that Tecta expression in both control and Mitomycin C treated cells was intracellular 
and no bright surface-associated aggregates were observed (Fig.3.6, c and c’). 
Intracellular Tecta expression in non-Mitomycin C treated cells (Fig.3.6, a and c) was 
even brighter than in Mitomycin C treated ones (Fig.3.6, a’ and c’). Although 
Mitomycin C treatment did not increase Tecta expression, it increased the size of the 
cells (Fig.3.6, b’ and c’). 
3.2.1.4. Influence of different substrates on Tecta expression 
As epithelial cells grow on a basement membrane in vivo, it is possible that cultivating 
stably transfected MDCK cells on various extracellular matrices would enhance cell 
polarisation and increase extracellular Tecta expression.  
Line 7 cells cultured on laminin (LM), poly-D-lysine (PDL), Matrigel
TM
 (MG) as well 
as control cells grown directly on a glass coverslip did not show a significant increase in 
the levels of extracellular Tecta expression (Fig.3.7, a, b, c and e). Interestingly, cells 
grown on MG could be characterised as sphere-shaped (Fig.3.7, c’). The highest levels 
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of Tecta expression that might be extracellular were observed for cells grown on 
ammonia-polymerised collagen (CG) (Fig.3.7, d and d’). Confocal microscopy of the 
CG-grown cells confirmed the extracellular localisation of Tecta aggregates (Fig.3.8). 
However, despite some success with enhancing extracellular expression of Tecta by 
culturing cells on an appropriate substrate, the small numbers of Tecta-positive cells 
still posed a problem in creating an effective model of Tecta expression.  
3.2.1.5. Stable cell lines generated with CAG promoter constructs 
New mammalian expression vectors utilising the CAG promoter composed of the 
cytomegalovirus immediate early enhancer (Foecking and Hofstetter, 1986) upstream of 
the chicken β-actin/rabbit β-globin (AG) promoter (Miyazaki et al., 1989; Niwa et al., 
1991) were used for stable transfection of MDCK cells. To enable cell screening for 
Tecta-positive cells with live fluorescence microscopy, mCherry, a red fluorescent 
protein with improved brightness and photostability, was fused to the N-terminal end of 
the Tecta protein. Fusing the mCherry and Tecta coding sequences gives an advantage 
of determining Tecta expression and localisation by mCherry fluorescence signal.  
Transient transfection of MDCK cells with pCAG-mCherry-Tecta along with EGFP-
Espin showed that the mCherry fluorescence signal had an intensity high enough to be 
detected at both low (Fig.3.9, a) and high (Fig.3.9, a’) magnifications. EGFP-Espin co-
transfection caused the prolongation of microvilli on cell apical surfaces. A cell line 
expressing mCherry-Tecta without EGFP-Espin was generated, as this allowed 
immunolabelling of Tecta through the GFP channel. 
After a final round of cloning, the cell monolayers of at least five selected clones 
observed using wide-field fluorescent microscopy appeared to be monoclonal in origin 
with each cell expressing mCherry (Fig.3.10, b). After seven days of culturing in vitro 
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the presence of several matrix aggregates on the cell apical surfaces was revealed by 
anti-Tecta staining (Fig.3.10, a and c). Confocal microscopy of the aggregates enclosed 
in the box on Fig.3.11 showed that mCherry-Tecta fusion protein formed amorphous 
aggregates on cell apical surface and green (Tecta) and red (mCherry) fluorescence 
signals co-localised as expected (Fig.3.11, c and c’). However, the co-localisation of 
Tecta and mCherry signals was not observed in all cells. Fig.3.12 shows an example of 
a cell found on the same glass coverslip as the cell in Fig.3.11. It displayed aggregates 
stained with anti-Tecta antibody as well as mCherry-only aggregates on the apical 
surface. 
Western blots of cell lysates and culture medium probed with anti-Tecta (R9) antibody 
revealed a broad band of approximately 260 kDa (Fig.3.13, b, lanes 3 and 4) which 
possibly represented the mCherry-Tecta fusion and was more distinct in cell lysates. 
Anti-RFP antibody detected a similar band with more protein and of slightly heavier 
mass in cell lysates (Fig.3.13, c, lane 5). In culture medium it revealed a double band 
which might represent glycosylated (larger band) and unglycosylated (smaller band, 
also detected with R9) forms of mCherry-Tecta (Fig.3.13, c, lane 6). These data might 
suggest that R9 does not react with glycosylated form of Tecta. Anti-RFP reacted with 
two additional bands of 60 and 63 kDa in both cell lysates and culture medium. As these 
bands were not detected by R9 antibody they possibly represent mCherry protein fused 
with a fragment of N-terminal Tecta. The western blotting experiments were repeated at 
least three times with consistent results. 
SEM of stable mCherry-Tecta cells detected mCherry-Tecta protein on the cell’s apical 
surface (Fig.3.14, a). However, Tecta failed to form filaments similar to those observed 
in vivo, and gold particles appeared to be tightly associated with microvilli and 
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protrusions (Fig.3.14, a). Since in vivo the TM matrix is normally formed by both Tecta 
and Tectb proteins, it was reasoned that co-expression with Tectb might enhance matrix 
formation. Confocal microscopy of the stable mCherry-Tecta cells co-transfected with 
the pBK-EGFP-Tectb construct showed that both Tecta and Tectb were secreted as 
small aggregates on cell apical surfaces. The expression patterns of the two proteins, 
however, hardly overlapped (Fig.3.15). No enhancement of tectorin aggregates was 
observed in response to co-expression. 
Hence, although using the pCAG-mCherry-Tecta vector enabled live selection by red 
fluorescence, the model still displayed some issues: 
1. mCherry-Tecta expressed on the apical cell surface could diffuse or be shed into 
the culture medium. 
2. Time course experiment repeated minimum three times showed that at least 7 
days of incubation were required for cells to accumulate sufficient extracellular 
mCherry-Tecta for detection by fluorescence microscopy (Fig.3.16). 
Consistent with the data for stable mCherry-Tecta cells, only a few extracellular EGFP-
Tectb punctae were observed in a minimum five examined clones of MDCK cells stably 
transfected with the pCAG-EGFP-Tectb construct after seven days of incubation 
(Fig.3.17). EGFP and anti-Tectb signals did not necessarily co-localise (Fig.3.17, c). 
Confocal microscopy provides an example of EGFP-Tectb fusion protein aggregates 
(Fig.3.18). 
Western blotting of cell lysates and culture medium with both anti-Tectb (Fig.3.19, b) 
and anti-GFP (Fig.3.19, d) antibodies repeated at least three times revealed a broad band 
at around 65 kDa corresponding to the mass expected for an EGFP-Tectb fusion protein. 
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In addition, the anti-Tectb antibody detected a broad band of approximately 43 kDa in 
both the cell lysates and the culture medium (Fig.3.19, b, lanes 3 and 4) which would 
correspond to Tectb protein lacking the EGFP fusion. EGFP protein was observed as 
multiple bands of around 25 kDa in the culture medium lane only (Fig.3.19, d, lane 8). 
The EGFP-Tectb and the Tectb proteins secreted into the culture medium were of a 
slightly higher mass than the proteins detected in cells. 
Thus, the Tectb stable cell line model encountered the same problems as the Tecta line: 
it took several days to produce matrix and much of the exported protein was secreted 
into the culture medium. 
3.2.2. Epithelial cell spheres as a model of Tecta expression 
Because one of the main disadvantages of a monolayer model was the loss of tectorins 
into the culture medium, the ability of MDCK cells to form hollow cysts in collagen-
Matrigel
TM
 mix (Sourisseau et al., 2006) was exploited to create a cellular “trap” for 
secreted proteins. The apical surfaces of the cells in such structures are directed inwards.  
Confocal microscopy of spheres formed from stably transfected mCherry-Tecta cells 
grown in collagen-Matrigel
TM
 mix for two weeks showed that mCherry-Tecta fusion 
protein accumulated within the lumen (Fig.3.20, a and b). mCherry signal was also 
detected within the cells (Fig.3.20, b and c). 
TEM analysis revealed that the sphere lumen was packed with matrix-like material 
(Fig.3.21). It consisted of fine branched interconnecting filaments with a diameter of 6-
9 nm which were attached to the microvilli. 
Thus polarised epithelial spheres were able to accumulate Tecta and produce a 
filamentous matrix in the lumen. However, the spheres took up to two weeks to produce 
high amounts of matrix which is consistent with previous studies (Witteveen, 2008). 
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Over this time cellular debris could accumulate inside the spheres too, making 
interpretation difficult. 
3.2.3. Matrix production in mouse cochlear cultures transiently transfected with 
recombinant tectorin constructs 
It is possible that problems observed in the epithelial cell monolayer and 3D culture 
models might be solved by using cultures of inner ear sensory epithelium, a system 
which normally builds the TM in vivo and might, therefore, meet all the requirements 
for effective tectorin secretion and matrix assembly. EGFP-Tectb and mCherry-Tecta 
encoding plasmids were delivered into wild type and Tecta
ΔENT/ΔENT
/Tectb null (Legan 
et al., 2000; Russell et al., 2007) mice cochlear explants by biolistic transfection with a 
helium gene gun. 
3.2.3.1. EGFP-Tectb expression 
Live fluorescence microscopy of wild type mouse inner ear explants revealed that gene 
gun transfection with pBK-EGFP-Tectb DNA triggered a robust production of matrix-
like material by different cell populations just 24 hours after transfection (Fig.3.22). 
Outgrowth zone cells produced a significant amount of EGFP-positive matrix forming 
either vermiculate structures (Fig.3.22, a and c) or amorphous masses (Fig.3.22, b) 
which appeared to be situated on the apical surfaces of the cells. In outer and inner hair 
cells, EGFP-signal appeared to associate with the hair bundle (Fig.3.22, d, e and f). 
Supporting cells of the GER that are characterised by a long narrow body and a small 
apical surface area expressed Tectb within the cytoplasm and produced a single patch of 
matrix on their apex (Fig.3.22, g, h and i). The same rapid EGFP-Tectb matrix 
production was observed in gene gun transfected cochlear cultures prepared from 
Tecta
ΔENT/ΔENT
/Tectb null mutant mice (Fig.3.23). 
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Confocal microscopy confirmed the extracellular nature of the EGFP-positive matrix 
aggregates generated by outgrowth zone cells (Fig.3.24). These aggregates ranged in 
shape and size from small grain-shaped matrix particles (Fig.3.24, a) to bigger 
amorphous aggregates (Fig.3.24, b and c) and thick strips of EGFP-positive material 
(Fig.3.24, d) that stayed in close contact with the plasma membrane (Fig.3.24, a’, b’, c’ 
and d’). GER cells expressed a fluffy-looking EGFP-positive material which was 
secreted onto the apical surface of the cell and appeared to be attached to the microvilli 
(Fig.3.25). In Deiter’s cells, amorphous matrix material covered the entire cell apical 
surface (Fig.3.26, a, b and c) and stayed in a close contact with cell microvilli as well 
(Fig.3.26, panels a’, b’ and c’). Fig.3.27 gives another example of Deiter’s and GER 
cells secreting extracellular matrix. In transfected outer and inner hair cells, EGFP-
positive matrix was detected at the distal area of the hair bundle where it formed a 
matrix cap around the tip of each stereocilium (Fig.3.28). Some EGFP-positive material 
was also present around the edge if the cell and had an extracellular nature (Fig.3.29). 
However, due to the damage caused by gene gun only five EGFP-Tectb transfected hair 
cells were examined in this thesis: three cells by confocal microscopy and two cells by 
TEM. 
Thus using gene gun transfection of mouse cochlear cultures as a model for studying 
Tectb expression provided the following advantages: 
1. Rapid matrix production was observed within 24 hours of transfection. 
2. Matrix production could be studied in different cell types. 
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3.2.3.2. Correlative light-electron microscopy of mouse cochlear cultures 
transiently expressing EGFP-Tectb 
Fig.3.30 shows a photomontage created from immunofluorescence images of a mouse 
cochlear culture that were transiently transfected with the construct encoding EGFP-
Tectb and stained with goat anti-GFP antibody after fixation. An outgrowth zone cell 
expressing high levels of EGFP-positive matrix on its apical surface organised in a few 
discrete bean-shaped aggregates (Fig.3.30, a and b) was chosen and subsequently 
identified using SEM. Prior to SEM imaging, the culture was re-stained with anti-Tectb 
antibody and labelled with gold-conjugated anti-rabbit antibody. Fig.3.31 illustrates the 
correlation between the light microscopy image of one of the matrix aggregates 
(Fig.3.31, a) on the apical surface of the outgrowth zone cell described above and the 
same structure imaged using SEM (Fig.3.31, b). SEM revealed that the bean-shaped 
aggregate on the surface of the outgrowth zone cell was an amorphous 3D structure 
which was attached to the cell by microvilli protruding from its edges (Fig.3.31, c). The 
aggregate was labelled with gold particles and therefore contains Tectb protein 
(Fig.3.31, d). 
Toluidine blue staining of a cross-section through an outgrowth zone cell that was first 
located by immunofluorescence labelling (Fig.3.32, a) and had EGFP-positive 
aggregates on its apical surface showed that these aggregates consist of amorphous 
extracellular material (Fig.3.32, b). TEM immunogold labelling confirmed the presence 
of Tectb (Fig.3.32, c) and showed that it consisted of amorphously organised material. 
No signs of filaments were detected (Fig.3.32, d). 
In an EGFP-positive hair cell detected in the second row of OHCs in a P2+1 wild type 
mouse cochlear culture (Fig.3.33, a) the signal localised to the hair bundle (Fig.3.33, b). 
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The correlative TEM of this OHC is shown on Fig.3.33, c. Gold labelling was detected 
at the distal tips of stereocilia which is consistent with the confocal microscopy results 
(Fig.3.28). Further investigation revealed that the EGFP-Tectb matrix expressed on the 
top of the hair bundle of OHCs and IHCs was of amorphous nature similar to that of the 
outgrowth zone cells (Fig.3.33, Fig.3.34).  
Thus mouse cochlear cultures were easier to map than cell monolayers, and transfected 
cells detected at light microscopy level could be found and then analysed by electron 
microscopy. 
3.2.3.3. mCherry-Tecta expression 
Despite the high levels of extracellular EGFP-Tectb expression observed in biolistically 
transfected outgrowth zone cells from neonatal mouse cochlear cultures, a similar effect 
was not detected using mCherry-Tecta encoding plasmids. 
Confocal microscopy investigation revealed that although pBK-mCherry-Tecta 
transfected outgrowth zone cells formed grain-shaped matrix punctae, these punctae 
were retained in the cell cytoplasm (Fig.3.35). In outgrowth zone cells transfected with 
the pCAG-mCherry-Tecta plasmid, mCherry-Tecta also formed discrete particles 
distributed intracellularly (Fig.3.36).  
To investigate whether the large size of the mCherry-Tecta protein can prevent 
outgrowth zone cells from secreting it as matrix, two constructs encoding shorter 
modifications of Tecta protein, pBK-mCherry-MMMTecta and pBK-mCherry-ZPTecta, 
were used for gene gun transfection. As shown by confocal microscopy, outgrowth zone 
cells transfected with these constructs had a large amount of protein aggregates 
distributed throughout the cell cytoplasm (Fig.3.37, a and b). These aggregates were, 
however, not secreted or deposited on the cell surface (Fig.3.37, a’ and b’). 
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Although transfected outgrowth zone cells failed to form extracellular matrix, mCherry-
Tecta secretion was sometimes detected on other cell types of mouse cochlear cultures. 
Fig.3.38 shows a confocal image of a Hensen’s cell transfected with the pBK-mCherry-
Tecta construct with an outburst of extracellular mCherry expression. Grain-shaped 
protein aggregates were present within the cell cytoplasm and were also found on its 
apical surface (Fig.3.38, a’ and c’). 
Confocal microscopy of a transfected OHC revealed that mCherry localised to the distal 
tips of the hair bundle (Fig.3.39). In contrast to EGFP-Tectb which formed a solid cap 
around the tips of stereocilia (Fig.3.28), mCherry-Tecta appeared like small spherical 
aggregates attached to the hair bundle (Fig.3.39, b). However, only two transfected 
OHCs were detected, and  this observation needs to be supported by increasing the 
number of performed hair cell transfections. 
In contrast to mCherry-Tecta transfected cells, a pBK-EGFP-Tecta construct promoted 
a robust extracellular expression of EGFP-positive aggregates in outgrowth zone cells 
(Fig.3.40) which resembled that in outgrowth zone cells transfected with the EGFP-
Tectb encoding construct. However, EGFP-Tecta transfected cells also retained the 
protein inside the cell bodies (Fig.3.40). Deiter’s cells also expressed protein inside and 
secreted it on their apical surface (Fig.3.41). GER cells displayed a high level of protein 
expression and produced a thick layer of extracellular matrix on their apical surfaces 
(Fig.3.42). 
3.2.3.4. Introduction of deafness-causing ZP domain mutations into Tectb 
Alignment of ZP domains from various proteins (chick Tectb, mouse Tecta, ZP3 
proteins from pig, mouse, human and hamster, mouse ZP2 protein, rat and human 
uromodulins, dog and rat GP2 proteins) identified cysteine and tyrosine amino acids in 
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mouse Tectb protein that are synonymous to those in human Tecta and are affected in 
human Spanish (C1837G) and Austrian (Y1870C) families with hereditary hearing loss 
(Fig.3.43). 
 
Figure 3.43. Fragments of ZP domains of various ZP proteins. Red horizontal boxes show mouse 
Tectb and human Tecta amino acid sequences. Red numbers mark the conserved cysteines, three of 
eight are shown. Orange box identifies the conserved cysteine replaced with glycine in the Spanish 
family. Green box shows the conserved tyrosine replaced with a cysteine in the Austrian family. 
Wide-field live fluorescence imaging showed that outgrowth zone cells transfected with 
the wild type Tectb-encoding construct formed bright matrix aggregates which localise 
extracellularly (Fig.3.44, a). However, cells transfected with the C1837G and Y1870C 
Tectb constructs lacked any matrix structures (Fig.3.44, b and c), and the even 
distribution of EGFP fluorescence signal throughout the cell body indicated the proteins 
derived from the mutated constructs were not secreted. 
Confocal microscopy results are consistent with live fluorescence imaging (Fig.3.45). 
Thus mutations in the ZP domain disrupt the process of matrix secretion. 
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3.3. Discussion 
The transient transfection experiment with the Tecta-IRES-turboFP635 construct 
showed that CaCo2 cells selected as a cell culture model for epithelia were unable to 
apically target recombinant Tecta. One of the possible explanations is that CaCo2 cells 
misinterpret the Tecta targeting signal. However, Tecta belongs to a group of GPI-
anchored proteins (Witteveen, 2008) which were shown to be secreted exclusively to 
the apical surface in epithelial cells with a very few exceptions (Brown and Breton, 
2000). Thus it is more likely that CaCo2 cells either fail to process and/or fold the 
protein correctly, which might result in the GPI signal being obscured. MDCK cells, in 
contrast, expressed a significant amount of Tecta aggregates among the apical microvilli. 
This result was supported by previous studies in which an MDCK cell line was 
successfully used as a model for apical expression of GPI-anchor proteins (Lisanti et al, 
1988).  
Following the results of the transient transfection, an MDCK cell line was utilised as a 
model system for investigating the secretion and assembly of tectorin matrix. While 
transient transfection is suitable for studying short-term protein production, stable 
extracellular expression of both tectorins is desirable for investigating the ultrastructure 
of secreted matrix by electron microscopy. A cell monolayer spread on a coverslip 
contains a large number of cells all of which have a similar form and it is hard to 
relocate transfected cells expressing fluorescent proteins in the electron microscope. 
Thus having a model in which every cell produces an extracellular matrix would 
significantly facilitate analysis by SEM and/or TEM. To determine how matrix 
assembly might be disrupted by deafness causing mutations in Tecta, a considerable 
surface expression of tectorins is required. Thus, MDCK-based cell lines stably 
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expressing Tecta and Tectb were generated by carefully selecting cells showing an 
extracellular tectorin expression.  
The first problem revealed while selecting cells stably transfected with the pBK-Tecta-
IRES-turboFP635 construct was an absence of fluorescence signal from the far-red 
turboFP635 protein during live imaging. As previous studies reported an excellent 
performance of turboFP635 in various in vivo applications, including cell selection, 
(Kelmanson, 2009), it was  suggested that the construct used contained a mutation either 
in the coding sequence of turboFP635 thus affecting its fluorescent properties or in the 
IRES, disrupting the translation of the fluorescent protein. Sequencing of the construct 
revealed a point mutation in the IRES which might explain why it was not possible to 
do live imaging. It is not known, however, whether this mutation affects IRES function. 
Other difficulties experienced while generating a Tecta-IRES-turboFP635 stable cell 
line were the low number of immunoreactive with anti-Tecta antibody, yet G418 
resistant, cells and even lower number of cells expressing Tecta on their apical surfaces. 
The Tecta encoding sequence was driven from the human CMV immediate early 
promoter. The efficiency of the CMV promoter is known to vary between different cell 
lines, being strong in some cell types and much weaker in others (Qin et al., 2010). In 
addition, silencing of this promoter was reported to be a problem while generating 
stable cell lines (Brooks et al., 2004; Löser et al., 1998). Silencing might occur due to 
the methylation of promoter sequences or histone deacetylation (Brooks et al., 2004; 
Grassi et al., 2003) and can explain the low number of cells in which Tecta expression 
could be detected.  
It was assumed that the appearance of Tecta on the cell’s apical surface might be a time-
dependent process and protein would have to accumulate to a certain level before it 
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could be detected. In any cell line that is actively dividing, the accumulation process 
might be disrupted by mitosis. This hypothesis was not confirmed as Mitomycin C-
induced block of cell division did not enhance the extracellular Tecta expression. 
It was further assumed that a suitable substrate imitating a basement membrane to 
which epithelial cells are attached in vivo might promote cell spreading, proliferation 
and the secretion and accumulation of matrix (Themistocleous et al., 2004). Cells were 
therefore grown on a collagen matrix composed of reconstituted collagen fibres that 
might simulate the cell- extracellular matrix (EMC) interactions that occur in vivo 
within epithelium systems. As predicted, it slightly promoted apical targeting of Tecta.  
As was mentioned above, the downregulation of the human CMV promoter while 
selecting for stably transfected cells prevented the accumulation of Tecta protein matrix. 
The composite CAG promoter (Niwa et al., 1991) was previously reported to be an 
invaluable tool for driving high-level and long-term gene expression from mammalian 
expression vectors (Alexopoulou et al., 2008; Chen et al., 2011; Nishijima et al., 2009). 
Fluorescent proteins are known to fold and function correctly when joined to other 
proteins (Snapp, 2010), so it should be possible to use the fluorescently tagged tectorins 
to directly study tectorin expression and distribution in live cells. This would also 
facilitate cell screening. Hence, a new set of Tecta and Tectb encoding constructs 
utilising the CAG promoter placed upstream of the fluorescent fusion protein coding 
sequence was designed. 
Although the CAG-based mammalian expression vectors allowed the generation of cell 
lines stably expressing Tecta and Tectb, the levels of extracellular matrix production 
remained quite low and it took about a week of culturing to obtain a detectable amount 
of surface-associated tectorin aggregates. In addition, both mCherry-Tecta and EGFP-
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Tectb were subjected to proteolysis and cleaved into mCherry and mCherry fused to 
LMM Tecta (Legan et al., 1997) and EGFP and Tectb, respectively. Interestingly, EGFP 
was only found in the medium and not in the cells. The abundant extracellular secretion 
of GFP protein was previously reported for different cell lines, however, only the 
improperly folded and thus non-fluorescent forms of protein were excreted (Tanudji, 
2002). The appearance of EGFP in culture medium and its absence in cell lysates 
probably reflects proteolysis of the secreted protein, possibly in the linker region 
between the two protein sequences. A slightly larger mass of the EGFP-Tectb and Tectb 
proteins detected in the medium might be explained by some posttranslational 
modification occurring before secretion, probably glycosylation.  
To circumvent the loss of protein into the culture medium, polarised epithelial cell 
spheres which “trap” secreted proteins in their lumen were generated from a mCherry-
Tecta stable cell line. With TEM, material could be detected inside the spheres that had 
assembled into fine interconnecting filaments with a diameter of 6-9 nm. Similar 
irregular branched filaments were detected in the TM of Tectb
-/-
 mutant mouse with 
completely disrupted striated-sheet matrix (Fig.3.46) (Russell et al., 2007). These 
filaments are thought to be made from Tecta and can be localised between the collagen 
fibrils (Fig.3.46, b). These data suggest that the fibrils detected in the sphere lumen 
might be formed of Tecta protein as well.  
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Figure 3.46. TEM images of the fibrils from the lumen of a sphere formed of cells stably transfected 
with mCherry-Tecta (a) and similar fibrils that are observed in the TM matrix of Tectb
-/-
 mouse (b). 
Fluffy branched filaments depicted in panel a are about 6-9 nm diameter and are similar to the 8 nm 
diameter filaments that are formed by Tecta (arrows) in the TM of the Tectb null mouse. Collagen 
fibrils are marked by arrowheads. Scale bar is 100 nm 
For in vitro matrix production, the best results were achieved using neonatal mouse 
cochlear cultures that had been transiently transfected with EGFP-Tectb encoding 
constructs using a gene gun. In addition to the cell types normally expressing Tectb 
protein in vivo, e.g. GER and Deiter’s cells, apical tectorin targeting was observed in 
transfected hair cells and outgrowth zone cells. 
An outgrowth zone emerges from the edge of the cochlear culture and has both 
epithelial and mesenchymal origins (He, 1997). It consists of mesenchymal cells and 
giant flat epithelial cells spread over the culture substrate. Transfected outgrowth zone 
cells secreted significant amounts of extracellular Tectb matrix to their apical surfaces 
just 24 hours after transfection. However, they failed to secrete mCherry-Tecta and its 
shortened versions which instead accumulated in the cytoplasm, indicating that the 
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failure of Tecta apical expression is not dependent on protein size. Interestingly, cells 
transfected with the EGFP-Tecta construct cause a robust extracellular matrix 
production in various cell-types. It is therefore possible that the mCherry fluorescent tag 
interferes with apical targeting of Tecta protein. 
The observed distribution of ectopically expressed tectorins in hair cells suggests the 
presence of a special receptor for Tecta and Tectb at the tip of a hair bundle. It is 
possible that the tectorins that are located to the distal end of stereocilia in transfected 
OHCs are becoming associated with the attachment crowns and interact with stereocilin. 
However, anti-stereocilin staining of the neonatal cochlear cultures showed that at the 
age of P2+1 stereocilin is expressed only in a kinocilium (Fig.3.47). Alternatively Tecta 
and Tectb may simply accumulate at the tips of stereocilia as a similar distribution is 
observed in IHCs, the mature bundles of which do not interact with the TM.  
TEM analysis revealed that outgrowth zone cells and hair cells express an amorphous 
Tectb matrix in which filaments cannot be resolved. It is possible that Tectb protein is 
unable to form a filament-based matrix without Tecta as was suggested to be the case in 
Tecta
ΔENT/
 
ΔENT
 mice (Legan et al., 2000). However, it also might be the case that the 
initial fixation was not good enough to preserve filaments. 
The final goal of this research was to study how deafness-causing mutations influence 
matrix assembly. The Tecta C1837G and Tecta Y1870C mutations were introduced into 
orthologous residues in the mouse Tectb ZP domain, and the mutated constructs were 
transfected into cochlear cultures. Outgrowth zone cells transfected with the mutated 
Tectb constructs failed to apically target the mutated polypeptides which accumulated 
instead in the cell cytoplasm. This result is consistent with the study of the Tecta
C1837G/+
 
mouse (Coates, 2009) and the Tecta
Y1870C/+ 
(Legan et al., 2005)
 
mouse in which  the 
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striated-sheet matrix is disrupted. Previous studies have showed that mutation 
synonymous to Y1870C in ZP2 protein essentially decreases its ability to incorporate in 
the zona pellucida and abolishes its extracellular expression in transfected CHO cells 
(Jovine et al., 2002). Both mutations affect the cysteine composition of ZP domain and 
hence might disrupt intrachain disulphide bond formation (Iwasaki et al., 2002). As a 
result, the incorrectly folded polypeptide will not be able to be exported to the cell’s 
apical membrane. 
Finally, the inability of Tecta and Tectb to form organised matrix might also be due to 
the absence of some other component of the TM which could be essential for proper 
protein assembly. This unknown component could be Ceacam16, a molecule recently 
described as a component of TM matrix that interacts with Tecta (Zheng et al., 2011). 
3.4. Conclusions 
The major findings of this study can be summarised as follows: 
1. MDCK cell lines stably expressing mCherry-Tecta and EGFP-Tectb produce 
limited amounts of “matrix” after prolonged periods in vitro. 
2. mCherry-Tecta forms filament-based matrix within the lumen of epithelial cell 
spheres. 
3. Transiently transfected epithelial cells in neonatal mouse cochlear cultures 
rapidly produce Tectb extracellular matrix. 
4. Deafness-causing ZP domain mutations prevent matrix formation in vitro. 
120 
 
3.5. Future perspectives 
The ultimate aim of this project was to study how deafness-causing mutations in Tecta 
affect TM matrix assembly. Thus the future work should aim to generate deafness-
causing mutations in the pBK-EGFP-Tecta construct using site directed mutagenesis 
and transfect the mutated vectors into the in vitro model system based on the neonatal 
mouse cochlear cultures. A higher transfection level might be possibly achieved by 
using electroporation as a transfection technique instead of the gene gun. Finally, the 
model developed might be useful for investigating the role of the recently described TM 
protein Ceacam16 in the maintenance of the striated-sheet matrix (Zheng et al., 2011). 
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CHAPTER 4
Phenotypic analysis of Ceacam16 null mutant 
mouse
4.1. Introduction
Ceacam16,  a  member  of  a  large  group  of  mammalian  immunoglobulin-related 
glycoproteins , is a secreted protein specifically expressed in the inner ear . A mutation 
in the Ceacam16 gene is thought to be the cause of human ADNSHL discovered in an 
American family . However, the role of Ceacam16 in normal hearing is unclear.  To 
reveal its possible function a Ceacam16 null mutant mouse model was generated. 
To study the changes in the inner ear morphology caused by the absence of Ceacam16 
and hence to understand its function in hearing and deafness, I analysed the phenotype 
of Ceacam16 null mutant mouse model generated as a part of this thesis.  
4.2. Results
4.2.1. Ceacam16 expression in a non-mutant mouse model
To  study  the  time  course  of  Ceacam16  expression  and  the  localisation  of  secreted 
Ceacam16  protein  in  a  non-mutant  mouse  model,  a  CD1  mouse  strain  was  used. 
Cryosections of cochleae obtained from CD1 mice pups of different ages were stained 
with anti-Ceacam16 antibody and Texas Red phalloidin. Although Ceacam16 protein is 
absent in the basal turn of the cochlea at P3 (Fig.4.1, a and a’), it can be detected at P9 
as a narrow region of immunoreactivity with the anti-Ceacam16 antibody on the surface 
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of a spiral limbus (Fig.4.1, b’), in the place of the TM attachment (Fig.4.1, b and b’). At 
P14 the staining spreads to the limbal and marginal zones of the TM and also appears 
around the edge of the TM main body (Fig.4.1, c and c’). However, Ceacam16 is not 
detected in the main body itself at this stage (Fig.4.1, c). Although all zones of the TM 
appear to be positive for Ceacam16 at P22, the staining is still brighter at the limbal and 
marginal zones (Fig.4.1, d and d’).
In the apical turns of the cochlea of a non-mutant mouse, Ceacam16 staining is not 
detected at P3 and P9 (Fig.4.2, a and a’, b and b’), but appears at P14 at the limbal and 
marginal zones of the TM (Fig.4.2, c and c’). As in the basal turns of the cochlea, the 
main body of the TM is not stained for Ceacam16 at P14 (Fig.4.2, c and c’). At P22 the 
entire TM body is immunoreactive with anti-Ceacam16 antibody. Like in the basal parts 
of the TM, the limbal and marginal zones are stained stronger (Fig.4.2, d and d’).
Western blotting of the TMs from P10, P12, P14 and P16 CD1 mouse pups indicates 
that Ceacam16 appears in the TM at P12 and produces a ladder of oligomeric forms 
under  reducing  conditions  (Fig.4.3).  The  amount  of  Ceacam16  protein  in  the  TM 
increases  between P12 and P16 (Fig.4.3).  As a  reference,  immunoblotting  was also 
performed with antibodies to other TM proteins: Tecta,  Tectb and collagen type IX. 
These proteins are already present in the TM at P10 and the levels of Tectb and collagen 
type  IX  expression  stay  stable  through  all  the  stages  examined  (Fig.4.3).  Tecta 
expression, however, continue to grow over the period from P10 to P16. 
Noteworthy,  the  onset  of  Ceacam16  expression  precedes  the  appearance  of  clearly 
defined striated sheet matrix which gains its mature appearance by P16 (Fig.4.4). This 
observation is consistent with the idea of Kammerer et al., 2012 that Ceacam16 protein 
is required for striated-sheet matrix formation.  
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4.2.2. Ceacam16 null mutant mouse model
4.2.2.1 βgal reporter expression
In the Ceacam16 null mutant mouse, exons 2-5 of the Ceacam16 gene are replaced with 
a β-galactosidase reporter and the cells in which Ceacam16 gene is active can be readily 
visualised with X-Gal staining. Fig.4.5 shows X-Gal-stained cochleae from P82 (a, b 
and  c)  and  6  months  old  (a’,  b’  and  c’)  Ceacam16+/+,  Ceacam16βgal/+ and 
Ceacam16βgal/βgal mice. X-Gal staining is not detected in wild type cochleae (Fig.4.5, a 
and a’). In heterozygous and homozygous mutant cochleae the staining appears along 
the  spiralling  organ  of  Corti  with  the  strongest  stain  seen  in  the  proximity  to  the 
helicotrema (Fig.4.5,  b  and b’,  c  and c’).  X-Gal  staining  observed in  heterozygotes 
(Fig.4.5, b and b’) is, as expected with only one copy of the βgal gene, weaker than that 
seen in homozygous mutants (Fig.4.5, c and c’). However, in both heterozygotes and 
mutants, X-Gal staining is stronger at 6 months than in the earlier stages, indicating that 
Ceacam16 expression lasts up to 6 months of age and may continue to increase (Fig.4.5, 
compare b and c with b’ and c’).
The detailed examination of cryosections of the organ of Corti from  Ceacam16βgal/βgal 
animals reveals that the β-galactosidase reporter is expressed in the epithelial cells of 
the  spiral  limbus  and inner  sulcus  (Fig.4.6).  X-Gal  staining  is  also  observed in  the 
Deiter’s  cells,  pillar  cells  and border cells  (Fig.4.6).  Obvious staining is not seen in 
outer and inner hair cells (Fig.4.6). Interestingly, there is a gradient in β-galactosidase 
reporter  expression through the length of the organ of Corti.  As revealed  by X-Gal 
staining, lacZ expression is weaker in the apical turns of the cochlea (Fig.4.7, a), but 
becomes  more  prominent  towards  the  basal  part  (Fig.4.7,  b).  A  comparative 
developmental  cryosection  series  from  the  apical  and  basal  turns  of  X-Gal-stained 
cochleae from mutant mice confirm the presence of this gradient from the early stages 
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of postnatal development (Fig.4.8). Expression of βgal starts from the basal turn of the 
cochlea  at  P8  (Fig.4.8,  b’),  where  X-Gal  staining  is  detected  in  the  border  cells 
(supporting cells lying medial to the IHCs), and reaches the apical end by P14 (Fig.4.8, 
e). However, in the sections examined, βgal expression in the border cells of the basal 
turn of the cochleae is downregulated at P10 and only the small patch of spiral limbus 
epithelial  cells  appears  to  react  with  X-Gal  (Fig.4.8,  c’).  By  P12,  lacZ  reporter 
expression spreads through the surface of the spiral limbus and inner sulcus and is also 
detected  in  the  border  cells  and the  third row of  Deiter’s  cells  (Fig.4.8,  d’).  X-Gal 
staining becomes brighter by P14 and also appears in the two other rows of Deiter’s cell 
and in the pillar cells (Fig.4.8, e’).  It is, however, more prominent in the outer pillar  
cell. βgal expression gets even stronger at P16 (Fig.4.8, f’). In the apical region of the 
organ of Corti X-Gal staining appears in the spiral limbus only by P14 (Fig.4.8, e). At 
P16, weak staining can be detected in the border and Deiter’s cells (Fig.4.8, f). Fig.4.9 
demonstrates that βgal expression is detected in the all cell types at stages of postnatal 
development later than P16. In mutant mice examined at P82, 6 months and 1 year, X-
Gal staining is observed in the spiral limbus, border cells, pillar cells and Deiter’s cells. 
4.2.2.2. LacZ reporter is not expressed in OHCs
In situ hybridisation experiments  suggested that Ceacam16 is expressed in OHCs, but 
is  absent  in  the  supporting  cells.  However,  in  the  present  study,  X-Gal  staining  of 
cryosections from the cochleae of Ceacam16 null mutant mice indicates that Ceacam16 
protein  is  expressed  in  Deiter’s  cells,  but  not  OHCs.  To  confirm  this  finding, 
cryosections  were  stained  with  anti-βgal  antibody  and  analysed  using  confocal 
microscopy  (Fig.4.10,  a).  Fluorescein  phalloidin  was  used  to  define  cell  borders 
(Fig.4.10, b). Consistent with the results obtained with X-Gal, anti-βgal immunostaining 
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is detected in Deiter’s cells (Fig.4.10, c), OHC bodies, however, do not react with the 
anti-βgal antibody (Fig.4.10, c).
4.2.2.3. Staining for Ceacam16 protein in the vestibular system of  Ceacam16 null 
mutant mouse
X-Gal  staining  is  not  detected  in  the  vestibular  system  of  Ceacam16βgal/+ and 
Ceacam16βgal/βgal  mice at the stages of postnatal development that were examined (P21, 
P82, 6 months and 1 year). As shown in Fig.4.11, the lateral crista, saccule and utricle 
from a P21 mutant animal do not have any signs of βgal reporter expression.
4.2.2.4. Protein composition of the TM in Ceacam16 null mutant mouse
Cryosections of the cochleae from  Ceacam16+/+,  Ceacam16+/βgal and  Ceacam16βgal/βgal 
mice  at  P21 were  stained with  soybean  agglutinin  (SBA,  or  lectin)  which  binds  to 
carbohydrate-containing  structures  to  study  the  distribution  of  the  glycoconjugates 
recognised by this  lectin  in the TM of mice  with these three genotypes.  Wide-field 
immunofluorescence microscopy indicates that the distribution appears to be similar in 
the wild type,  heterozygous and homozygous mutant  animals.  Fig.4.12 demonstrates 
that SBA reacts with the marginal band, covernet and the limbal zone of the TM in all 
three genotypes. 
To determine whether the lack of Ceacam16 protein can influence the expression of 
other  inner  ear  components,  cryosections  from  the  cochleae  of  Ceacam16+/+, 
Ceacam16+/βgal and  Ceacam16βgal/βgal mice at  P21 were stained with antibodies  to the 
following proteins:  Tecta,  Tectb,  collagen type  IX, otogelin and the TM attachment 
protein  otoancorin  (Fig.4.13).  Staining  for  Ceacam16  was  also  performed,  and  in 
accordance with expectations it is strong in the Ceacam16+/+ mouse cochlea (Fig.4.13, 
a),  weaker  in  the  Ceacam16+/βgal (Fig.4.13,  b)  and  is  completely  absent  in  the 
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Ceacam16βgal/βgal mouse  (Fig.4.13,  c).  Ceacam16  staining  in  both  wild  type  and 
heterozygous animals locates to the limbal and marginal zones of the TM (Fig.4.13, a, 
and b). No differences in the distribution or expression levels of the other proteins are 
observed.
It is possible that the protein composition and arrangement in the inner ear of a mutant 
mouse might change with time. Thus the staining with antibodies to inner ear proteins 
was repeated for Ceacam16+/+, Ceacam16+/βgal and Ceacam16βgal/βgal mice at 6 months of 
age. As indicated in Fig.4.14, the results obtained are similar to P21 data: staining with 
anti-Ceacam16 antibody is present only in wild type and heterozygous animals (a and 
b), mainly in the marginal and limbal zones of the TM; no differences in the distribution 
of  otoancorin,  Tecta,  otogelin  and  collagen  type  IX  are  detected.  However,  Tectb 
protein  levels  in  the  main  body of  the  TM appear  to  be  decreased  in  homozygous 
mutants (Fig.4.14, l) which might indicate a time dependent drop-off in Tectb levels in 
Ceacam16βgal/βgal mice.  The  Tectb  staining  in  heterozygote  and  wild  type  TMs  is 
comparable.
To verify whether the amount of tectorins in the TM of Ceacam16βgal/βgal mice decreases 
with time, quantification from western blots of TMs harvested from heterozygous and 
mutant  animals  at  the  age  of  1  month  and  6  months  was  carried  out.  No  visible 
difference  is  detected  for  Tecta  and  Tectb  bands  between  Ceacam16+/βgal and 
Ceacam16βgal/βgal animals at 1 month of age (Fig.4.15, a). Although the tectorin bands are 
weaker at 6 months of age for both heterozygotes and mutants, the Tectb protein band 
from  Ceacam16βgal/βgal mice  seems  to  be  the  most  drastically  affected  (Fig.4.15,  a). 
Quantification of the western blots confirms that Tecta levels do not differ significantly 
at 1 month and 6 months of age in the mutant mice (Fig.4.15, b). However, the amount 
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of Tectb in  Ceacam16βgal/βgal mice at 6 months of age is considerably less than at one 
month of age (Fig.4.15, b).
To  identify  whether  Tectb  and  Ceacam16  proteins  interact  once  secreted,  culture 
medium from HEK293 cells transiently transfected with constructs encoding Tectb and 
Ceacam16-V5  was  analysed  using  co-immunoprecipitation  (Co-IP)  and 
immunoblotting. The antibodies used for pulling down proteins and western blotting, as 
well as the results expected for a Tectb/Ceacam16 interaction are presented in Table 
4.1.
Antibody 
used  for 
Co-IP
Antibody 
used  for 
western 
blotting
Transient transfection used to obtain culture medium
Sham Tectb Ceacam16-
V5
Tectb+Ceacam16-
V5
Anti-Tectb Anti-Tectb - + - +
Monoclonal 
anti-V5
- - - +
Polyclonal 
anti-V5
Anti-Tectb - - - +
Monoclonal 
anti-V5
- - + +
Table 4.1. The expected results of Co-IP assay and western blotting in case secreted Tectb and 
Ceacam16  are  interacting  partners.  Sign  “-“  marks  the  combination  of  antibodies  and  culture 
medium where no bands are expected on PVDF membrane. Sign “+” identified the position where 
the bands are expected.
As shown in Fig.4.16, proteins pulled down with anti-Tectb and then blotted with anti-
Tectb and anti-V5 antibodies reveals a similar pattern of background staining for both 
PVDF membranes  with  no secreted  Tectb  band detected  (Fig.4.16,  a).  No proof  of 
interaction between Ceacam16 and Tectb is detected (Fig.4.16,  a and b). Anti-Tectb 
staining of samples pulled down by anti-V5 antibody as well uncovers only non-specific 
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bands  (Fig.4.16,  c).  Anti-V5  staining  of  anti-V5  co-immunoprecipitates  gives  two 
specific bands in the Ceacam16 lane and one band in Ceacam16+Tectb lane (Fig.4.16, 
d). The high molecular weight material at 160 kDa forms a narrow band in the top of 
the Ceacam16 lane.  The broad 65-75 kDa band is detected in the Ceacam16 lane, a 
lesser density band of 175 kDa is found in the Ceacam16+Tectb lane. These bands are 
likely to represent those Ceacam16 oligomers which are secreted in the culture medium.
4.2.2.5.  No  changes  in  Ceacam16 expression  are  detected  in  mouse  models  for 
Tecta deafness-causing mutations
As was suggested by studies of  , Ceacam16 protein might directly interact with Tecta. 
However, no changes in Tecta content in the TM of Ceacam16+/βgal and Ceacam16βgal/βgal  
mice were observed using immunofluorescence  microscopy and quantifying  western 
blotting.  It  is  possible,  however,  that  deafness  mutations  in  Tecta  which  cause 
alterations in the TM matrix, might have an effect on Ceacam16 protein expression. 
Hence, cryosections of cochleae from three transgenic mice generated as models for 
Tecta mutations found in Spanish (C1837G), French (C1619S) and Belgian (L1820F, 
G1824D) families with ADNSHL (1.5.1.3) were stained with anti-Ceacam16 antibody 
and examined using confocal microscopy. As shown in Fig.4.17, in the transgenic mice 
models  for Tecta  mutations  examined,  Ceacam16 protein is  expressed in apical  and 
basal turns of the cochleae throughout the entire body of the TM in all genotypes.
4.2.2.6.  The  TM  matrix  is  less  dense  in  the  apical  turn  of  the  cochlea  in 
Ceacam16βgal/βgal mice
Toluidine blue staining of 1 µm sections from the organ of Corti of  Ceacam16 null 
mutant mice indicates that the density of the TM in Ceacam16βgal/βgal animals is reduced 
(Fig.4.18). The lack of the matrix in the main body of the TM is especially prominent in 
129
the apical turn of the cochlea (Fig.4.18, c). A less severe decrease in the TM density is 
observed in the 20 kHz (basal 1) region of the organ of Corti (Fig.4.18, f). Although the 
TM in  the  40  kHz  (basal  2)  region  has  a  normal  density,  it  lacks  Hensen’s  stripe 
(Fig.4.18, i) which is present in wild type and heterozygous animals (Fig.4.18, g and h). 
The organ of Corti of  Ceacam16+/βgal mice appears to be similar to that of wild type 
animals, hence, no obvious phenotype is present in heterozygotes up to 6 months of age 
at the light microscopy level.
4.2.2.7.  Ultrastuctural  analysis  of  the  TM in  Ceacam16+/βgal and  Ceacam16βgal/βgal  
mice
TEM analysis confirms the normal appearance of striated-sheet matrix in the apical and 
basal cochlear turns of Ceacam16+/βgal mice (Fig.4.19, a and a’). In the Ceacam16βgal/βgal 
mouse disrupted striated-sheet matrix can be seen at P30, the earliest stage examined 
(Fig.4.19, b and b’). The apical turn of the mutant cochlea is characterised by sparsely 
packed filaments located between collagen fibrils. The matrix of the mutant basal TM is 
densely packed but does not appear to be clearly structured (Fig.4.19, b’). The covernet 
has  a  normal  organisation  in  the  Ceacam16+/βgal and  the  Ceacam16βgal/βgal mice 
(Fig.4.20). TEM analysis also confirms the observation that the TM of mutant animals 
lacks Hensen’s stripe in the basal turns of the cochlea (Fig.4.21).
4.3. Discussion
X-Gal staining reveals that the main sources of Ceacam16 expression in the adult mouse 
cochlea  (P21)  are  interdental  cells  of  the spiral  limbus,  epithelial  cells  of  the inner 
sulcus epithelia, border cells, pillar cells and Deiter’s cells. Expression in the Deiter’s 
cells  and its absence in OHCs, however, conflicts  with the findings of Zheng et al., 
2011, who located Ceacam16 mRNA to OHCs and did not detect it in Deiter’s cells of 
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P42 mice. This can possibly be explained by the optical overlap of the Deiter’s cells 
protrusions with the bodies of OHCs causing Zheng et al. to misidentify the origin of 
the  staining.  It  might  be  argued  that  the  Deiter’s  cells  protrusions  are  secreting 
Ceacam16 protein which diffuses to the main body of the TM .
Lectin  staining  demonstrated  the  presence  of  glycoconjugates  in  the  limbal  zone, 
covernet  and  marginal  zone  of  the  TM  in  the  Ceacam16 null  mutant  mouse.  No 
abnormalities were described for the content and distribution of collagen IX, otogelin 
and  otoancorin  proteins  in  Ceacam16+/βgal and  Ceacam16βgal/βgal mice  at  P21  and  6 
months of age. Previous studies suggested that Ceacam16 and Tecta proteins might be 
interacting partners . However, no decrease in Tecta levels was detected in Ceacam16 
null mutant mice using immunofluorescence staining and quantitative western blotting. 
Ceacam16 protein was also detected in the TM of mouse models for Tecta missense 
mutations  in  the  ZA  (French  mutation)  and  ZP  (Belgium  and  Spanish  mutations) 
domains  which  potentially  can  disrupt  the  ability  of  Tecta  to  interact  with  other 
proteins.  However,  a  significant  decrease  in  the  levels  of  Tectb  in  the  TM  of  the 
Ceacam16βgal/βgal mice was observed by the age of 6 months, suggesting that Tectb might 
interact with Ceacam16. Co-immunoprecipitation assays and western blotting detected 
high levels of Ceacam16 protein secreted in the cell culture medium but failed to detect 
extracellular Tectb secretion. One of the possible explanations might be that the anti-
Tectb antibody was unable to pull down the proteins in a co-immunoprecipitation assay. 
However, a Ceacam16 band observed in the Ceacam16+Tectb co-transfection lane is 
much weaker than in the Ceacam16-only lane which might indicate that Tectb remains 
within  the  cytoplasm  where  it  interacts  with  Ceacam16  protein  and  prevents  its 
secretion.
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The data obtained from the toluidine blue stained sections of the organ of Corti showed 
that the main body of the TM in the apical turns of the cochlea of Ceacam16βgal/βgal mice 
contains a reduced amount of matrix. The TEM data revealed a complete disruption of 
the striated-sheet matrix in the apical TM of mutant animals which may explain the low 
frequency hearing loss in DFNA4 patients. In the basal turns of the TM the phenotype 
is, however, less prominent and includes amorphous filaments densely packed between 
collagen fibrils and the absence of Hensen’s stripe. Interestingly, X-Gal staining reveals 
transient  βgal  expression  in  the  border  cells,  located  underneath  the  developing 
Hensen’s stripe, in the basal turn of the organ of Corti in a mutant mouse at P8. This  
observation indicates that Ceacam16 expression from border cells might be essential for 
the development of the Hensen’s stripe. 
In  summary,  the  data  indicate  that  Ceacam16  is  involved  in  the  formation  of  the 
striated-sheet  matrix  of  the  TM.  A  possible  mechanism  of  interaction  between 
Ceacam16,  Tecta  and  Tectb  proteins  has  been  proposed  by Kammerer  et  al.,  2012 
(Fig.4.22).  Tecta  and  Tectb  proteins  were  suggested  to  interact  through  their  ZP 
domains thus producing dark fibrils of striated-sheet matrix. Ceacam16 proteins might 
form dimers through the disulfide bonds between their IgC2-like subtype B domains. 
They might then interact with each other through their IgV-like domains thus giving the 
light-stained fibrils.  Dark and light-stained fibrils could be connected by the bridges 
formed by Tecta. This model, however, does not suggest the direct interaction between 
Tectb and Ceacam16.
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Figure  4.22.  Possible  organisation  of  Tecta,  Tectb  and  Ceacam16  in  striated-sheet  matrix. 
Ceacam16 molecules interact through their IgC-like B domains forming two disulfide bonds and 
thus associating in dimers. IgV-like N2 domains of Ceacam16 molecules from different dimers form 
one disulfide bond connecting Ceacam16 dimers in a staggered structure that might form a dark 
filament. Light filaments are supposed to be formed by the ZP domain of Tecta and Tectb proteins. 
Dark fibrils are attached to the Ent domain of Tecta through IgV-like N1 domains. Hence, Tecta  
protein forms bridges between alternating dark and light fibrils. N1 - IgV-like N1 domain, A and B - 
IgC-like domains subtypes A and B. Ent - Tecta entactin domain, 0-4 - Tecta von Willebrand factor 
domains, ZP - Tecta zona pellucida domain. Yellow bar depicts a region of no significant homology 
with other proteins, black bar indicates for GPI-anchor. Modified from .
These  studies  also  suggest  that  Ceacam16  might  be  involved  in  the  long-term 
maintenance of the TM. In the cochleae of non-mutant mice, the onset of  Ceacam16 
mRNA expression  is  detected  at  E17  and overlaps  with the expression of  tectorin 
mRNAs which starts from E12.5 but shuts down by P15 . While Ceacam16 expression 
lasts into adulthood, Tecta and Tectb are synthesised in a 3-week period and stay stable 
throughout the life time of the organism (Rau et al., 1999). This suggests that Ceacam16 
might act as a matrix-stabiliser and is essential for preservation of TM composition . 
Although both tectorins are expressed in the vestibular system, X-Gal staining does not 
reveal Ceacam16 expressing cells in the vestibule of the Ceacam16 null mutant mice. 
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These data are consistent with Ceacam16 role in formation of striated-sheet matrix and 
maintenance of its stability (Kammerer et al., 2012; Zheng et al., 2011). In a non-mutant 
mouse model, Ceacam16 protein is detected by P9 as a thin cover over the spiral limbus 
and by P12 appears in the TM as a ladder of oligomeric forms confirming the results 
obtained by Zheng et al. in 2011.
No physiological measurements for Ceacam16 null mutant mice were performed in this 
research project. However, the 4 weeks old Ceacam16 null mice with targeted deletion 
of exons 2-4 and a part of exon 5 generated by Kammerer et al. had hearing impairment 
which progressed with age. The mutant animals displayed an elevated hearing threshold 
for frequencies below 10 kHz and above 22 kHz and reduced cochlear amplification. 
However, the vulnerability of  Ceacam16 to noise exposure was comparable to that in 
wild type animals. In addition, age-related hearing in both mutant and wild type animals 
progressed in a similar way.
4.4. Conclusions
The major findings regarding the role of Ceacam16 protein in the TM are summarised 
below:
1. Ceacam16 expression in the TM precedes the striated-sheet  matrix  formation 
and the onset of hearing.
2. Ceacam16  protein  is  essential  for  striated-sheet  matrix  formation  and  may 
maintain stability of this matrix over time.
3. The  amount  of  Tectb  protein  drastically  decreases  with  time  in  the 
Ceacam16βgal/βgal mouse.
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4. Loss of striated-sheet matrix from the apical end of the tectorial membrane may 
account for the low frequency hearing loss in DFNA4 patients. 
5. No phenotype was discovered in Ceacam16+/βgal animals.
4.5. Future prospectives
Future studies of  Ceacam16 null mutant mouse model are needed to find out whether 
there  is  a  special  phenotype  for  Ceacam16+/βgal mice.  Although  no  phenotype  was 
discovered for heterozygotes  up to  6 months,  preliminary TEM data indicate  that  it 
might appear later. It is worth studying whether Ceacam16 null mutant mice are more 
vulnerable  to  noise  exposure  or  if  they  age  differently  to  non-mutant  animals.  The 
central focus of research should, however, be on physiological assessment of the mutant 
mice  hearing.  To describe  the  heterozygous  and mutant  phenotypes  fully  it  will  be 
necessary  to  perform  auditory  brainstem  response (ABR)  and  distortion  product 
otoacoustic emissions (DPOAE) measurements, to define changes in TM stiffness and 
to  measure  compound  action  potential  (CAP).  An  in  vitro model  of  TM  matrix 
assembly  described  in  Chapter  2  might  be  helpful  for  finding  out  the  potential 
interactions of Ceacam16 protein with other components of the TM.
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CONCLUSIONS
This  work  has  been  focused  on  the  non-collagenous  components  of  the  tectorial 
membrane  matrix  which  are  involved  in  the  striated-sheet  matrix  formation.  It  has 
provided an in vitro model for studying the processing, secretion and assembly of the 
tectorins and an in vivo model for revealing the function of newly described inner ear 
protein Ceacam16. The major conclusions of this thesis can be summarised as follows:
1. Epithelial  cells in primary cultures of the early postnatal cochlea are the best 
suited for studying the production and assembly of extracellular tectorin-based 
matrix.
2. Outgrowth zone cells of the neonatal mouse cochlear cultures probably possess 
enzymes and chaperons necessary for extracellular tectorin secretion in vitro.
3. Ceacam16  protein  is  required  for  striated-matrix  formation  and/or  for 
maintenance the TM stability over time.
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